,explicit_doi,bibref,retrieved_local_doi,retrieved_remote_doi,manual_doi,local_score
0,,"Mendoza, L, Vilela, R, Voelz, K, Ibrahim, AS, Voigt, K, Lee, SC. Human fungal pathogens of mucorales and entomophthorales, Cold Spring Harb Perspect Med, 2015, 5, pii: a019562 doi: 10.1101/cshperspect.a019562",10.1101/cshperspect.a019562,10.1101/cshperspect.a019562,10.1101/cshperspect.a019562,72.662285
1,,"Prabhu, RM, and Patel, R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations, diagnosis and treatment, Clin Microbiol Infect, 2004, 10, 31, 47, PMID: 14748801",10.1111/j.1470-9465.2004.00843.x,10.1111/j.1470-9465.2004.00843.x,10.1111/j.1470-9465.2004.00843.x,42.04508
4,,"Bittencourt, AL, Marback, R, Nossa, LMB. Mucocutaneous entomoptharomycosis acquired by conjunctival inoculation of the fungus, Am J Trop Med Hyg, 2006, 75, 936, 8, PMID: 17123991",10.4269/ajtmh.2006.75.936,10.4269/ajtmh.2006.75.936,10.4269/ajtmh.2006.75.936,45.697792
5,10.1128/cmr.18.3.556-569.2005,"Spellberg, B, Edwards, J, Jr, Ibrahim, A. Novel perspectives on mucormycosis: Pathophysiology, presentation, and management, Clin Microbiol Rev, 2005, 18, 556, 69, PMID: 16020690",10.1128/cmr.18.3.556-569.2005,10.1128/cmr.18.3.556-569.2005,10.1128/cmr.18.3.556-569.2005,40.40983
6,10.1371/journal.pntd.0003984,"Blumentrath, CG, Grobusch, MP, Matsiégui, PB, Pahlke, F, Zoleko-Manego, R, Nzenze-Aféne, S. Classification of rhinoentomophthoromycosis into atypical, early, intermediate, and late disease: A proposal, PLoS Negl Trop Dis, 2015, 9, e0003984, PMID: 26426120",10.1371/journal.pntd.0003984,10.1371/journal.pntd.0003984,10.1371/journal.pntd.0003984,81.46619
7,,"Gugnani, HC. Entomophthoromycosis due to conidiobolus, Eur J Epidemiol, 1992, 8, 391, 6, PMID: 1397203",10.1007/bf00158574,10.1007/bf00158574,10.1007/bf00158574,41.15529
11,10.1037/0033-2909.133.3.482,"Levin, R, Nielsen, T.A. Disturbed dreaming, posttraumatic stress disorder, and affect distress: A review and neurocognitive model, Psychol. Bull, 2007, 133, 482, 528, DOI: 10.1037/0033-2909.133.3.482, PMID: 17469988",10.1037/0033-2909.133.3.482,10.1037/0033-2909.133.3.482,10.1037/0033-2909.133.3.482,61.801704
12,,"Schredl, M. Researching Dreams: The Fundamentals, 1st ed, Palgrave Macmillan, Cham, Switzerland, 2018",10.1007/978-3-319-95453-0,10.1007/978-3-319-95453-0,10.1007/978-3-319-95453-0,20.636910999999998
13,10.1037/a0037749,"Böckermann, M, Gieselmann, A, Pietrowsky, R. What does nightmare distress mean? Factorial structure and psychometric properties of the Nightmare Distress Questionnaire (NDQ), Dreaming, 2014, 24, 279, 289, DOI: 10.1037/a0037749",10.1037/a0037749,10.1037/a0037749,10.1037/a0037749,92.32751999999999
14,10.1037/0021-843x.101.3.592,"Belicki, K. Nightmare fequency versus nightmare distress: Relation to psychopathology and cognitive style, J. Abnorm. Psychol, 1992, 101, 592, 597, DOI: 10.1037/0021-843X.101.3.592, PMID: 1500619",10.1037/0021-843x.101.3.592,10.1037/0021-843x.101.3.592,10.1037/0021-843x.101.3.592,63.59035
15,10.1037/h0094355,"Belicki, K. The relationship of nightmare frequency to nightmare suffering with implications for treatment and research, Dreaming, 1992, 2, 143, 148, DOI: 10.1037/h0094355",10.1037/h0094355,10.1037/h0094355,10.1037/h0094355,62.538776
16,10.1037/drm0000039,"Lee, R, Suh, S. Nightmare distress as a mediator between nightmare frequency and suicidal ideation, Dreaming, 2016, 26, 308, 318, DOI: 10.1037/drm0000039",10.1037/drm0000039,10.1037/drm0000039,10.1037/drm0000039,67.8095
17,10.1016/j.paid.2006.03.010,"Roberts, J, Lennings, C.J. Personality, psychopathology and nightmares in young people, Pers. Individ. Differ, 2006, 41, 733, 744, DOI: 10.1016/j.paid.2006.03.010",10.1016/j.paid.2006.03.010,10.1016/j.paid.2006.03.010,10.1016/j.paid.2006.03.010,43.50991
18,10.5935/1984-0063.20190080,"Schredl, M, Göritz, A.S. Nightmare frequency and nightmare distress: Socio-demographic and personality factors, Sleep Sci, 2019, 12, 178, 184, DOI: 10.5935/1984-0063.20190080, PMID: 31890093",10.5935/1984-0063.20190080,10.5935/1984-0063.20190080,10.5935/1984-0063.20190080,49.061809999999994
19,10.1007/s00406-003-0438-1,"Schredl, M. Effects of state and trait factors on nightmare frequency, Eur. Arch. Psychiatry Clin. Neurosci, 2003, 253, 241, 247, DOI: 10.1007/s00406-003-0438-1, PMID: 14504993",10.1007/s00406-003-0438-1,10.1007/s00406-003-0438-1,10.1007/s00406-003-0438-1,51.369614
20,10.1159/000343590,"Swart, M.L, van Schagen, A.M, Lancee, J, van den Bout, J. Prevalence of nightmare disorder in psychiatric outpatients, Psychother. Psychosom, 2013, 82, 267, 268, DOI: 10.1159/000343590, PMID: 23735876",10.1159/000343590,10.1159/000343590,10.1159/000343590,75.025215
21,,"Pack, A.I, Keenan, B.T, Byrne, E.M, Gehrman, P.R. Genetics and genomic basis of sleep disorders in humans, Principles and Practice of Sleep Medicine, 6th ed, Kryger, M, Roth, T, Dement, W.C. Elsevier, Philidelphia, PA, USA, 2017, 322, 339",10.1016/b978-0-323-24288-2.00031-3,10.1016/b978-0-323-24288-2.00031-3,10.1016/b978-0-323-24288-2.00031-3,52.39699
22,10.1037/pspp0000099,"Lipnevich, A.A, Credè, M, Hahn, E, Spinath, F.M, Roberts, R.D, Preckel, F. How distinctive are morningness and eveningness from the Big Five factors of personality? A meta-analytic investigation, J. Pers. Soc. Psychol, 2017, 112, 491, 509, DOI: 10.1037/pspp0000099, PMID: 27977220",10.1037/pspp0000099,10.1037/pspp0000099,10.1037/pspp0000099,80.02717
23,10.1080/07420520902750995,"Tonetti, L, Fabbri, M, Natale, V. Relationship between Circadian Typology and Big Five Personality Domains, Chronobiol. Int, 2009, 26, 337, 347, DOI: 10.1080/07420520902750995, PMID: 19212845",10.1080/07420520902750995,10.1080/07420520902750995,10.1080/07420520902750995,58.76521999999999
24,10.1007/s40675-018-0113-8,"Kivelä, L, Papadopoulos, M.R, Antypa, N. Chronotype and Psychiatric Disorders, Curr. Sleep Med. Rep, 2018, 4, 94, 103, DOI: 10.1007/s40675-018-0113-8, PMID: 29888167",10.1007/s40675-018-0113-8,10.1007/s40675-018-0113-8,10.1007/s40675-018-0113-8,58.320384999999995
25,10.1177/0748730409351677,"Nielsen, T. Nightmares associated with eveningness chronotype, J. Biol. Rhythms, 2010, 25, 53, 62, DOI: 10.1177/0748730409351677, PMID: 20075301",10.1177/0748730409351677,10.1177/0748730409351677,10.1177/0748730409351677,52.646477000000004
26,10.1111/j.1479-8425.2011.00511.x,"Selvi, Y, Aydin, A, Gulec, M, Boysan, M, Besiroglu, L, Ozdemir, P.G, Kilic, S. Comparison of dream anxiety and subjective sleep quality between chronotypes, Sleep Biol. Rhythms, 2012, 10, 14, 22, DOI: 10.1111/j.1479-8425.2011.00511.x",10.1111/j.1479-8425.2011.00511.x,10.1111/j.1479-8425.2011.00511.x,10.1111/j.1479-8425.2011.00511.x,68.73198000000001
27,10.1177/2158244017728321,"Randler, C, Schredl, M, Göritz, A.S. Chronotype, Sleep Behavior, and the Big Five Personality Factors, SAGE Open, 2017, 7, 1, 9, DOI: 10.1177/2158244017728321",10.1177/2158244017728321,10.1177/2158244017728321,10.1177/2158244017728321,61.44433000000001
28,10.1038/nature10190,"Lederbogen, F, Kirsch, P, Haddad, L, Streit, F, Tost, H, Schuch, P, Wust, S, Pruessner, J.C, Rietschel, M, Deuschle, M. City living and urban upbringing affect neural social stress processing in humans, Nature, 2011, 474, 498, 501, DOI: 10.1038/nature10190, PMID: 21697947",10.1038/nature10190,10.1038/nature10190,10.1038/nature10190,77.955956
29,10.1002/mpr.1439,"Jacobi, F, Höfler, M, Siegert, J, Mack, S, Gerschler, A, Scholl, L, Busch, M.A, Hapke, U, Maske, U, Seiffert, I. Twelve-month prevalence, comorbidity and correlates of mental disorders in Germany: The Mental Health Module of the German Health Interview and Examination Survey for Adults (DEGS1-MH), Int. J. Methods Psychiatr. Res, 2014, 23, 304, 319, DOI: 10.1002/mpr.1439, PMID: 24729411",10.1002/mpr.1439,10.1002/mpr.1439,10.1002/mpr.1439,88.8026
31,10.1023/b:drem.0000005912.77493.d6,"Stepansky, R, Holzinger, B, Schmeiser-Rieder, A, Saletu, B, Kunze, M, Zeitlhofer, J. Austrian dream behavior: Results of a representative population survey, Dreaming, 1998, 8, 23, 30, DOI: 10.1023/B:DREM.0000005912.77493.d6",10.1023/b:drem.0000005912.77493.d6,10.1023/b:drem.0000005912.77493.d6,10.1023/b:drem.0000005912.77493.d6,78.64264
32,10.1007/s00406-010-0112-3,"Schredl, M. Nightmare frequency and nightmare topics in a representative German sample, Eur. Arch. Psychiatry Clin. Neurosci, 2010, 260, 565, 570, DOI: 10.1007/s00406-010-0112-3, PMID: 20229263",10.1007/s00406-010-0112-3,10.1007/s00406-010-0112-3,10.1007/s00406-010-0112-3,72.9109
33,10.1111/jsr.12416,"Sandman, N, Merikanto, I, Määttänen, H, Valli, K, Kronholm, E, Laatikainen, T, Partonen, T, Paunio, T. Winter is coming: Nightmares and sleep problems during seasonal affective disorder, J. Sleep Res, 2016, 25, 612, 619, DOI: 10.1111/jsr.12416, PMID: 27174375",10.1111/jsr.12416,10.1111/jsr.12416,10.1111/jsr.12416,88.80891
34,10.2466/pms.106.3.699-702,"Schredl, M. Dream recall frequency in a representative German sample, Percept. Mot. Skills, 2008, 106, 699, 702, DOI: 10.2466/pms.106.3.699-702, PMID: 18712190",10.2466/pms.106.3.699-702,10.2466/pms.106.3.699-702,10.2466/pms.106.3.699-702,70.03737
35,10.2466/pms.108.3.677-680,"Schredl, M. Recall frequency of positive and negative dreams in a representative German sample, Percept. Mot. Skills, 2009, 108, 677, 680, DOI: 10.2466/pms.108.3.677-680, PMID: 19725304",10.2466/pms.108.3.677-680,10.2466/pms.108.3.677-680,10.2466/pms.108.3.677-680,72.59295999999999
37,10.1111/j.1365-2869.2004.00394.x,"Blagrove, M, Farmer, L, Williams, E. The relationship of nightmare frequency and nightmare distress to well-being, J. Sleep Res, 2004, 13, 129, 136, DOI: 10.1111/j.1365-2869.2004.00394.x, PMID: 15175092",10.1111/j.1365-2869.2004.00394.x,10.1111/j.1365-2869.2004.00394.x,10.1111/j.1365-2869.2004.00394.x,61.301880000000004
39,10.3390/biology8030054,"Roenneberg, T, Pilz, L.K, Zerbini, G, Winnebeck, E.C. Chronotype and Social Jetlag: A (Self-) Critical Review, Biology, 2019, 8, 54, DOI: 10.3390/biology8030054",10.20944/preprints201905.0092.v1,10.3390/biology8030054,10.3390/biology8030054,49.393715
40,10.1046/j.1439-054x.2001.01149.x,"Griefahn, B, Künemund, C, Bröde, P, Mehnert, P. Zur Validität der deutschen Übersetzung des Morningness-Eveningness-Questionnaires von Horne und Östberg, Somnology, 2001, 5, 71, 80, DOI: 10.1046/j.1439-054X.2001.01149.x",10.1046/j.1439-054x.2001.01149.x,10.1046/j.1439-054x.2001.01149.x,10.1046/j.1439-054x.2001.01149.x,54.627069999999996
41,10.3109/07420528.2011.635232,"Vollmer, C, Michel, U, Randler, C. Outdoor Light at Night (LAN) Is Correlated With Eveningness in Adolescents, Chronobiol. Int, 2012, 29, 502, 508, DOI: 10.3109/07420528.2011.635232, PMID: 22214237",10.3109/07420528.2011.635232,10.3109/07420528.2011.635232,10.3109/07420528.2011.635232,54.083893
42,10.1016/j.cub.2013.06.039,"Wright, K.P, McHill, A.W, Birks, B.R, Griffin, B.R, Rusterholz, T, Chinoy, E.D. Entrainment of the Human Circadian Clock to the Natural Light-Dark Cycle, Curr. Biol, 2013, 23, 1554, 1558, DOI: 10.1016/j.cub.2013.06.039, PMID: 23910656",10.1016/j.cub.2013.06.039,10.1016/j.cub.2013.06.039,10.1016/j.cub.2013.06.039,65.00618
43,10.1037/0021-843x.99.1.64,"Wood, J.M, Bootzin, R.R. The prevalence of nightmares and their independence from anxiety, J. Abnorm. Psychol, 1990, 99, 64, 68, DOI: 10.1037/0021-843X.99.1.64, PMID: 2307768",10.1037/0021-843x.99.1.64,10.1037/0021-843x.99.1.64,10.1037/0021-843x.99.1.64,52.655437
44,10.1037/0021-843x.109.2.273,"Zadra, A.L, Donderi, D.C. Nightmares and bad dreams: Their prevalence and relationship to well-being, J. Abnorm. Psychol, 2000, 109, 273, 281, DOI: 10.1037/0021-843X.109.2.273, PMID: 10895565",10.1037/0021-843x.109.2.273,10.1037/0021-843x.109.2.273,10.1037/0021-843x.109.2.273,65.25007
45,10.1111/j.1365-2869.2008.00649.x,"Robert, G, Zadra, A.L. Measuring nightmare and bad dream frequency: Impact of retrosepective and prospective instruments, J. Sleep Res, 2008, 17, 132, 139, DOI: 10.1111/j.1365-2869.2008.00649.x, PMID: 18482103",10.1111/j.1365-2869.2008.00649.x,10.1111/j.1365-2869.2008.00649.x,10.1111/j.1365-2869.2008.00649.x,54.313083999999996
47,10.1093/sleep/zsaa116,"Vallat, R, Nicolas, A, Ruby, P. Brain functional connectivity upon awakening from sleep predicts inter-individual differences in dream recall frequency, Sleep, 2020, zsaa116, DOI: 10.1093/sleep/zsaa116, PMID: 32597973",10.1093/sleep/zsaa116,10.1093/sleep/zsaa116,10.1093/sleep/zsaa116,80.6351
49,10.2466/pms.98.3.1422-1426,"Schredl, M. Reliability and stability of a dream recall frequency scale, Percept. Mot. Skills, 2004, 98, 1422, 1426, DOI: 10.2466/PMS.98.3.1422-1426, PMID: 15291233",10.2466/pms.98.3c.1422-1426,10.2466/pms.98.3c.1422-1426,10.2466/pms.98.3c.1422-1426,70.82637
54,10.1055/s-2007-986199,"Körner, A, Geyer, M, Roth, M, Drapeau, M, Schmutzer, G, Albani, C, Schumann, S, Brahler, E. Personlichkeitsdiagnostik mit dem NEO-Fünf-Faktoren-Inventar: Die 30-Item-Kurzversion (NEO-FFI-30) [Personality diagnostic using the NEO-Five-Factor-Inventory: The 30-Item short version (NEO-FFI-30)], Psychother. Psychosom. Med. Psychol, 2008, 58, 238, 245, DOI: 10.1055/s-2007-986199, PMID: 17899495",10.1055/s-2007-986199,10.1055/s-2007-986199,10.1055/s-2007-986199,114.06055
56,10.1001/jama.2020.1227,"Emanuel, EJ. The inevitable reimagining of medical education, JAMA, 2020, 323, 12, 1127, 1128, DOI: 10.1001/jama.2020.1227, PMID: 32105294",10.1001/jama.2020.1227,10.1001/jama.2020.1227,10.1001/jama.2020.1227,41.062637
57,10.1056/nejmp1706474,"Schwartzstein, RM, Roberts, DH. Saying goodbye to lectures in medical school — paradigm shift or passing fad, New Engl J Med, 2017, 377, 7, 605, 607, DOI: 10.1056/nejmp1706474, PMID: 28813217",10.1056/nejmp1706474,10.1056/nejmp1706474,10.1056/nejmp1706474,68.51454
61,10.1177/105256298200700103,"Michaelsen, LK, Watson, W, Cragin, JP, Fink, LD. Team learning: a potential solution to the problems of large classes, J Organ Behav Educ, 1982, 7, 1, 13, 22, DOI: 10.1177/105256298200700103",10.1177/105256298200700103,10.1177/105256298200700103,10.1177/105256298200700103,48.8593
62,10.1007/s10459-006-9012-8,"Dolmans, DH, Schmidt, HG. What do we know about cognitive and motivational effects of small group tutorials in problem-based learning, Adv Health Sci Educ, 2006, 11, 4, 321, 336, DOI: 10.1007/s10459-006-9012-8",10.1007/s10459-006-9012-8,10.1007/s10459-006-9012-8,10.1007/s10459-006-9012-8,68.50166
63,,"Wray A, Wolff M, Boysen-Osborn M, Wiechmann W, Paradise P, Runcie E, Sudario G, Toohey S. Not another boring resident didactic conference. AEM Educ Train. 2019;4(S1). 10.1002/aet2.10367",10.1002/aet2.10367,10.1002/aet2.10367,10.1002/aet2.10367,63.730072
64,10.1007/s10461-020-02837-x,"Marhefka, S, Lockhart, E, Turner, D. Achieve research continuity during social distancing by rapidly implementing individual and group videoconferencing with participants: key considerations, best practices, and protocols, AIDS Behav, 2020, 24, 1983, 1989, DOI: 10.1007/s10461-020-02837-x, PMID: 32240428",10.1007/s10461-020-02837-x,10.1007/s10461-020-02837-x,10.1007/s10461-020-02837-x,84.94869
66,10.1001/jama.1995.03520300057037,"Perednia, DA, Allen, A. Telemedicine technology and clinical applications, JAMA, 1995, 273, 6, 483, 488, DOI: 10.1001/jama.1995.03520300057037, PMID: 7837367",10.1001/jama.273.6.483,10.1001/jama.273.6.483,10.1001/jama.273.6.483,44.037678
67,10.1146/annurev.publhealth.21.1.613.perednia,"Bashshur, RL, Reardon, TG, Shannon, GW. Telemedicine: a new health care delivery system, Annu Rev Public Health, 2000, 21, 1, 613, 637, DOI: 10.1146/annurev.publhealth.21.1.613.Perednia, PMID: 10884967",10.1146/annurev.publhealth.21.1.613,10.1146/annurev.publhealth.21.1.613,10.1146/annurev.publhealth.21.1.613,55.071915000000004
68,10.1016/j.tics.2010.09.003,"Roediger, HL, Butler, AC. The critical role of retrieval practice in long-term retention, Trends Cogn Sci, 2011, 15, 1, 20, 27, DOI: 10.1016/j.tics.2010.09.003, PMID: 20951630",10.1016/j.tics.2010.09.003,10.1016/j.tics.2010.09.003,10.1016/j.tics.2010.09.003,37.841496
69,,"Shepard, LA. Formative assessment: caveat emptor. In: Dwyer CA. The future of assessment: shaping teaching and learning, 2008, New York, Routledge",10.4324/9781315086545-12,10.4324/9781315086545-12,10.4324/9781315086545-12,29.070679
70,10.1016/j.humov.2013.01.002,"Agostini, V, Chiaramello, E, Canavese, L, Bredariol, C, Knaflitz, M. Postural sway in volleyball players, Hum Mov Sci, 2013, 32, 445, 456, DOI: 10.1016/j.humov.2013.01.002, PMID: 23628360",10.1016/j.humov.2013.01.002,10.1016/j.humov.2013.01.002,10.1016/j.humov.2013.01.002,58.271626
71,10.1007/s11332-008-0056-4,"Alpini, D, Mattei, V, Schlecht, H, Kohen-Raz, R. Postural control modifications induced by synchronized ice skating, Sport Sci Health, 2008, 3, 11, 17, DOI: 10.1007/s11332-008-0056-4",10.1007/s11332-008-0056-4,10.1007/s11332-008-0056-4,10.1007/s11332-008-0056-4,75.30237
72,10.1080/02640414.2010.544046,"Kuczyński, M, Szymańska, M, Bieć, E. Dual-task effect on postural control in high-level competitive dancers, J Sports Sci, 2011, 29, 539, 545, DOI: 10.1080/02640414.2010.544046, PMID: 21294035",10.1080/02640414.2010.544046,10.1080/02640414.2010.544046,10.1080/02640414.2010.544046,57.153397
73,10.1007/s00421-011-2151-5,"Stambolieva, K, Diafas, V, Bachev, V, Christova, L, Gatev, P. Postural stability of canoeing and kayaking young male athletes during quiet stance, Eur J Appl Physiol, 2012, 112, 1807, 1815, DOI: 10.1007/s00421-011-2151-5, PMID: 21909987",10.1007/s00421-011-2151-5,10.1007/s00421-011-2151-5,10.1007/s00421-011-2151-5,90.05058000000001
74,10.1080/1750984x.2012.723728,"Wulf, G. Attentional focus and motor learning: a review of 15 years, Int Rev Sport Exerc Psychol, 2013, 6, 77, 104, DOI: 10.1080/1750984X.2012.723728",10.1080/1750984x.2012.723728,10.1080/1750984x.2012.723728,10.1080/1750984x.2012.723728,41.075947
75,10.1123/ijspp.2015-0211,"Ihalainen, S, Linnamo, V, Mononen, K, Kuitunen, S. Relation of elite rifle shooters’ technique-test measures to competition performance, Int J Sports Physiol Perform, 2016, 11, 671, 677, DOI: 10.1123/ijspp.2015-0211, PMID: 26559498",10.1123/ijspp.2015-0211,10.1123/ijspp.2015-0211,10.1123/ijspp.2015-0211,73.52644000000001
76,10.1016/0021-9290(95)00066-6,"Era, P, Konttinen, N, Mehto, P, Saarela, P, Lyytinen, H. Postural stability and skilled performance-a study on top-level and naive rifle shooters, J Biomech, 1996, 29, 301, 306, DOI: 10.1016/0021-9290(95)00066-6, PMID: 8850636",10.1016/0021-9290(95)00066-6,10.1016/0021-9290(95)00066-6,10.1016/0021-9290(95)00066-6,73.6542
78,10.1055/s-2004-830529,"Asseman, F, Caron, O, Crémieux, J. Effects of the removal of vision on body sway during different postures in elite gymnasts, Int J Sports Med, 2005, 26, 116, 119, DOI: 10.1055/s-2004-830529, PMID: 15726495",10.1055/s-2004-830529,10.1055/s-2004-830529,10.1055/s-2004-830529,75.47015
79,10.1016/j.neulet.2003.12.102,"Asseman, F, Caron, O, Crémieux, J. Is there a transfer of postural ability from specific to unspecific postures in elite gymnasts, Neurosci Lett, 2004, 358, 83, 86, DOI: 10.1016/j.neulet.2003.12.102, PMID: 15026154",10.1016/j.neulet.2003.12.102,10.1016/j.neulet.2003.12.102,10.1016/j.neulet.2003.12.102,66.55903
80,,"Sell, TC, Tsai, Y-S, Smoliga, JM, Myers, JB, Lephart, SM. Strength, flexibility, and balance characteristics of highly proficient golfers, J Strength Cond Res, 2007, 21, 4, 1166, 1171, PMID: 18076270",10.1519/r-21826.1,10.1519/r-21826.1,10.1519/r-21826.1,61.981018000000006
81,10.1080/02640414.2017.1306090,"Kim, M, Kim, Y, Kim, H, Yoon, B. Specific muscle synergies in national elite female ice hockey players in response to unexpected external perturbation, J Sports Sci, 2018, 36, 319, 325, DOI: 10.1080/02640414.2017.1306090, PMID: 28415899",10.1080/02640414.2017.1306090,10.1080/02640414.2017.1306090,10.1080/02640414.2017.1306090,62.333957999999996
82,10.1016/j.gaitpost.2007.09.007,"Gautier, G, Thouvarecq, R, Vuillerme, N. Postural control and perceptive configuration: influence of expertise in gymnastics, Gait Posture, 2008, 28, 46, 51, DOI: 10.1016/j.gaitpost.2007.09.007, PMID: 17976990",10.1016/j.gaitpost.2007.09.007,10.1016/j.gaitpost.2007.09.007,10.1016/j.gaitpost.2007.09.007,59.214130000000004
83,,"Kuczyński M, Rektor Z, Borzucka D. Postural control in quiet stance in the second league male volleyball players. Hum Mov. 2009;10. 10.2478/v10038-008-0025-4.",10.2478/v10038-008-0025-4,10.2478/v10038-008-0025-4,10.2478/v10038-008-0025-4,69.714485
84,10.1371/journal.pone.0096440,"Welch, TDJ, Ting, LH. Mechanisms of motor adaptation in reactive balance control, PLoS One, 2014, 9, e96440, DOI: 10.1371/journal.pone.0096440, PMID: 24810991",10.1371/journal.pone.0096440,10.1371/journal.pone.0096440,10.1371/journal.pone.0096440,49.083565
85,10.1007/s001670000147,"Söderman, K, Werner, S, Pietilä, T, Engström, B, Alfredson, H. Balance board training: prevention of traumatic injuries of the lower extremities in female soccer players, Knee Surgery, Sport Traumatol Arthrosc, 2000, 8, 356, 363, DOI: 10.1007/s001670000147",10.1007/s001670000147,10.1007/s001670000147,10.1007/s001670000147,79.48393
86,10.1177/0363546503262177,"Verhagen, E, van der Beek, A, Twisk, J, Bouter, L, Bahr, R, van Mechelen, W. The effect of a proprioceptive balance board training program for the prevention of ankle sprains, Am J Sports Med, 2004, 32, 1385, 1393, DOI: 10.1177/0363546503262177, PMID: 15310562",10.1177/0363546503262177,10.1177/0363546503262177,10.1177/0363546503262177,80.33629599999999
87,10.1177/0363546505284191,"McGuine, TA, Keene, JS. The effect of a balance training program on the risk of ankle sprains in high school athletes, Am J Sports Med, 2006, 34, 1103, 1111, DOI: 10.1177/0363546505284191, PMID: 16476915",10.1177/0363546505284191,10.1177/0363546505284191,10.1177/0363546505284191,64.681694
88,10.1109/10.532130,"Prieto, TE, Myklebust, JB, Hoffmann, RG, Lovett, EG, Myklebust, BM. Measures of postural steadiness: differences between healthy young and elderly adults, IEEE Trans Biomed Eng, 1996, 43, 956, 966, DOI: 10.1109/10.532130, PMID: 9214811",10.1109/10.532130,10.1109/10.532130,10.1109/10.532130,71.03345999999999
89,10.1016/s0966-6362(99)00003-x,"Kuczyński, M. The second order autoregressive model in the evaluation of postural stability, Gait Posture, 1999, 9, 50, 56, DOI: 10.1016/S0966-6362(99)00003-X, PMID: 10575070",10.1016/s0966-6362(99)00003-x,10.1016/s0966-6362(99)00003-x,10.1016/s0966-6362(99)00003-x,49.029579999999996
91,10.1093/ageing/afl077,"Horak, FB. Postural orientation and equilibrium: what do we need to know about neural control of balance to prevent falls, Age Ageing, 2006, 35, 7, 11, DOI: 10.1093/ageing/afl077",10.1093/ageing/afl077,10.1093/ageing/afl077,10.1093/ageing/afl077,66.16154
92,10.1097/jes.0b013e3182877cc8,"Haddad, JM, Rietdyk, S, Claxton, LJ, Huber, JE. Task-dependent postural control throughout the lifespan, Exerc Sport Sci Rev, 2013, 41, 123, 132, DOI: 10.1097/JES.0b013e3182877cc8, PMID: 23364347",10.1097/jes.0b013e3182877cc8,10.1097/jes.0b013e3182877cc8,10.1097/jes.0b013e3182877cc8,58.994476
93,,Paillard T. Relationship between sport expertise and postural skills. Front Psychol. 2019;10. 10.3389/fpsyg.2019.01428.,10.3389/fpsyg.2019.01428,10.3389/fpsyg.2019.01428,10.3389/fpsyg.2019.01428,43.890827
94,10.1080/02701367.2008.10599495,"Wulf, G. Attentional focus effects in balance acrobats, Res Q Exerc Sport, 2008, 79, 319, 325, DOI: 10.1080/02701367.2008.10599495, PMID: 18816943",10.1080/02701367.2008.10599495,10.1080/02701367.2008.10599495,10.1080/02701367.2008.10599495,40.50318
95,10.1080/02724980143000118,"Wulf, G, McNevin, N, Shea, CH. The automaticity of complex motor skill learning as a function of attentional focus, Q J Exp Psychol A, 2001, 54, 1143, 1154, DOI: 10.1080/02724980143000118, PMID: 11765737",10.1080/713756012,10.1080/713756012,10.1080/713756012,50.350765
96,10.1080/02701367.2001.10608970,"Wulf, G, Shea, C, Park, J-H. Attention and motor performance: preferences for and advantages of an external focus, Res Q Exerc Sport, 2001, 72, 335, 344, DOI: 10.1080/02701367.2001.10608970, PMID: 11770783",10.1080/02701367.2001.10608970,10.1080/02701367.2001.10608970,10.1080/02701367.2001.10608970,48.038303000000006
97,10.3200/jmbr.36.2.189-199,"Wulf, G, Mercer, J, McNevin, N, Guadagnoli, MA. Reciprocal influences of Attentional focus on postural and Suprapostural task performance, J Mot Behav, 2004, 36, 189, 199, DOI: 10.3200/JMBR.36.2.189-199, PMID: 15130869",10.3200/jmbr.36.2.189-199,10.3200/jmbr.36.2.189-199,10.3200/jmbr.36.2.189-199,70.26695
98,10.1111/j.1365-2923.2009.03421.x,"Wulf, G, Shea, C, Lewthwaite, R. Motor skill learning and performance: a review of influential factors, Med Educ, 2010, 44, 75, 84, DOI: 10.1111/j.1365-2923.2009.03421.x, PMID: 20078758",10.1111/j.1365-2923.2009.03421.x,10.1111/j.1365-2923.2009.03421.x,10.1111/j.1365-2923.2009.03421.x,47.871086
99,10.1016/j.cobeha.2018.01.004,"Sternad, D. It’s not (only) the mean that matters: variability, noise and exploration in skill learning, Curr Opin Behav Sci, 2018, 20, 183, 195, DOI: 10.1016/j.cobeha.2018.01.004, PMID: 30035207",10.1016/j.cobeha.2018.01.004,10.1016/j.cobeha.2018.01.004,10.1016/j.cobeha.2018.01.004,46.459396000000005
100,10.1016/j.gaitpost.2016.02.019,"Casabona, A, Leonardi, G, Aimola, E, La Grua, G, Polizzi, CM, Cioni, M. Specificity of foot configuration during bipedal stance in ballet dancers, Gait Posture, 2016, 46, 91, 97, DOI: 10.1016/j.gaitpost.2016.02.019, PMID: 27131184",10.1016/j.gaitpost.2016.02.019,10.1016/j.gaitpost.2016.02.019,10.1016/j.gaitpost.2016.02.019,72.079994
101,10.1007/s00221-016-4814-2,"Cone, BL, Goble, DJ, Rhea, CK. Relationship between changes in vestibular sensory reweighting and postural control complexity, Exp Brain Res, 2017, 235, 547, 554, DOI: 10.1007/s00221-016-4814-2, PMID: 27812748",10.1007/s00221-016-4814-2,10.1007/s00221-016-4814-2,10.1007/s00221-016-4814-2,67.38086
102,10.1371/journal.pone.0021815,"Huang, HJ, Ahmed, AA. Tradeoff between stability and maneuverability during whole-body movements, PLoS One, 2011, 6, e21815, DOI: 10.1371/journal.pone.0021815, PMID: 21779336",10.1371/journal.pone.0021815,10.1371/journal.pone.0021815,10.1371/journal.pone.0021815,56.125927000000004
103,10.1016/j.gaitpost.2016.11.034,"Acasio, J, Wu, M, Fey, NP, Gordon, KE. Stability-maneuverability trade-offs during lateral steps, Gait Posture, 2017, 52, 171, 177, DOI: 10.1016/j.gaitpost.2016.11.034, PMID: 27915220",10.1016/j.gaitpost.2016.11.034,10.1016/j.gaitpost.2016.11.034,10.1016/j.gaitpost.2016.11.034,56.320994999999996
104,,"Le Mouel C, Brette R. Mobility as the purpose of postural control. Front Comput Neurosci. 2017;11. 10.3389/fncom.2017.00067.",10.3389/fncom.2017.00067,10.3389/fncom.2017.00067,10.3389/fncom.2017.00067,50.184067
105,10.1016/j.gaitpost.2011.10.354,"Pau, M, Kim, S, Nussbaum, MA. Does load carriage differentially alter postural sway in overweight vs. normal-weight schoolchildren, Gait Posture, 2012, 35, 378, 382, DOI: 10.1016/j.gaitpost.2011.10.354, PMID: 22088849",10.1016/j.gaitpost.2011.10.354,10.1016/j.gaitpost.2011.10.354,10.1016/j.gaitpost.2011.10.354,67.4843
106,10.1126/science.aad4998,"Seh, ZW. Combining theory and experiment in electrocatalysis: insights into materials design, Science, 2017, 355, eaad4998, DOI: 10.1126/science.aad4998, PMID: 28082532",10.1126/science.aad4998,10.1126/science.aad4998,10.1126/science.aad4998,40.305065
107,10.1021/acs.chemrev.5b00462,"Shao, M, Chang, Q, Dodelet, J-P, Chenitz, R. Recent advances in electrocatalysts for oxygen reduction reaction, Chem. Rev, 2016, 116, 3594, 3657, DOI: 10.1021/acs.chemrev.5b00462, PMID: 26886420",10.1021/acs.chemrev.5b00462,10.1021/acs.chemrev.5b00462,10.1021/acs.chemrev.5b00462,59.666059999999995
108,10.1016/s1369-7021(08)70254-2,"Sealy, C. The problem with platinum, Mater. Today, 2008, 11, 65, 68, DOI: 10.1016/S1369-7021(08)70254-2",10.1016/s1369-7021(08)70254-2,10.1016/s1369-7021(08)70254-2,10.1016/s1369-7021(08)70254-2,31.150990999999998
109,10.1038/35104620,"Steele, BCH, Heinzel, A. Materials for fuel-cell technologies, Nature, 2001, 414, 345, 352, DOI: 10.1038/35104620, PMID: 11713541",10.1038/35104620,10.1038/35104620,10.1038/35104620,45.855442
110,10.1016/j.apcatb.2004.06.021,"Gasteiger, HA, Kocha, SS, Sompalli, B, Wagner, FT. Activity benchmarks and requirements for Pt, Pt-alloy, and non-Pt oxygen reduction catalysts for PEMFCs, Appl. Catal. B Environ, 2005, 56, 9, 35, DOI: 10.1016/j.apcatb.2004.06.021",10.1016/j.apcatb.2004.06.021,10.1016/j.apcatb.2004.06.021,10.1016/j.apcatb.2004.06.021,66.48664000000001
111,10.1149/1.2130665,"Kinumoto, T. Stability of Pt-catalyzed highly oriented pyrolytic graphite against hydrogen peroxide in acid solution, J. Electrochem. Soc, 2006, 153, A58, A63, DOI: 10.1149/1.2130665",10.1149/1.2130665,10.1149/1.2130665,10.1149/1.2130665,53.211117
112,10.1016/j.electacta.2007.11.010,"Ramaswamy, N, Hakim, N, Mukerjee, S. Degradation mechanism study of perfluorinated proton exchange membrane under fuel cell operating conditions, Electrochim. Acta, 2008, 53, 3279, 3295, DOI: 10.1016/j.electacta.2007.11.010",10.1016/j.electacta.2007.11.010,10.1016/j.electacta.2007.11.010,10.1016/j.electacta.2007.11.010,59.413734
113,10.1149/1.2801980,"Sethuraman, VA, Weidner, JW, Haug, AT, Motupally, S, Protsailo, LV. Hydrogen peroxide formation rates in a PEMFC anode and cathode, J. Electrochem. Soc, 2008, 155, B50, B57, DOI: 10.1149/1.2801980",10.1149/1.2801980,10.1149/1.2801980,10.1149/1.2801980,63.67785
114,10.1149/1.3210685,"Wu, G. Performance durability of polyaniline-derived non-precious cathode catalysts, ECS Trans, 2009, 25, 1299, 1311, DOI: 10.1149/1.3210685",10.1149/1.3210685,10.1149/1.3210685,10.1149/1.3210685,42.431973
115,10.1038/2011212a0,"Jasinski, R. A new fuel cell cathode catalyst, Nature, 1964, 201, 1212, 1213, DOI: 10.1038/2011212a0",10.1038/2011212a0,10.1038/2011212a0,10.1038/2011212a0,49.65501
116,10.1149/1.2423590,"Jasinski, R. Cobalt phthalocyanine as a fuel cell cathode, J. Electrochem. Soc, 1965, 112, 526, DOI: 10.1149/1.2423590",10.1149/1.2423590,10.1149/1.2423590,10.1149/1.2423590,43.461459999999995
117,10.1595/205651318x696828,"Jaouen, F. Toward platinum group metal-free catalysts for hydrogen/air proton-exchange membrane fuel cells, Johns. Matthey Technol. Rev, 2018, 62, 231, 255, DOI: 10.1595/205651318X696828",10.1595/205651318x696828,10.1595/205651318x696828,10.1595/205651318x696828,53.904823
118,10.1126/science.1170051,"Lefèvre, M, Proietti, E, Jaouen, F, Dodelet, J-P. Iron-based catalysts with improved oxygen reduction activity in polymer electrolyte fuel cells, Science, 2009, 324, 71, 74, DOI: 10.1126/science.1170051, PMID: 19342583",10.1126/science.1170051,10.1126/science.1170051,10.1126/science.1170051,66.606575
119,10.1016/j.electacta.2008.02.012,"Bezerra, CWB. A review of Fe–N/C and Co–N/C catalysts for the oxygen reduction reaction, Electrochim. Acta, 2008, 53, 4937, 4951, DOI: 10.1016/j.electacta.2008.02.012",10.1016/j.electacta.2008.02.012,10.1016/j.electacta.2008.02.012,10.1016/j.electacta.2008.02.012,39.009785
120,10.1021/jacs.7b05130,"Liu, W. Discriminating catalytically active FeN, x species of atomically dispersed Fe–N–C catalyst for selective oxidation of the C–H bond, J. Am. Chem. Soc, 2017, 139, 10790, 10798, DOI: 10.1021/jacs.7b05130, PMID: 28745500",10.1021/jacs.7b05130,10.1021/jacs.7b05130.s001,10.1021/jacs.7b05130,60.37169
121,10.1039/c2cp41957b,"Kramm, UI. Structure of the catalytic sites in Fe/N/C-catalysts for O, 2-reduction in PEM fuel cells, Phys. Chem. Chem. Phys, 2012, 14, 11673, 11688, DOI: 10.1039/c2cp41957b, PMID: 22824866",10.1039/c2cp41957b,10.1039/c2cp41957b,10.1039/c2cp41957b,47.062954
122,10.1021/jp0266087,"Bouwkamp-Wijnoltz, AL. On active-site heterogeneity in pyrolyzed carbon-supported iron porphyrin catalysts for the electrochemical reduction of oxygen: an, in situ Mössbauer study, J. Phys. Chem. B, 2002, 106, 12993, 13001, DOI: 10.1021/jp0266087",10.1021/jp0266087,10.1021/jp0266087,10.1021/jp0266087,67.26706999999999
123,10.1016/s0022-0728(02)01189-0,"Bron, M, Radnik, J, Fieber-Erdmann, M, Bogdanoff, P, Fiechter, S. EXAFS, XPS and electrochemical studies on oxygen reduction catalysts obtained by heat treatment of iron phenanthroline complexes supported on high surface area carbon black, J. Electroanal. Chem, 2002, 535, 113, 119, DOI: 10.1016/S0022-0728(02)01189-0",10.1016/s0022-0728(02)01189-0,10.1016/s0022-0728(02)01189-0,10.1016/s0022-0728(02)01189-0,81.45708499999999
124,10.1038/nmat4367,"Zitolo, A. Identification of catalytic sites for oxygen reduction in iron-and nitrogen-doped graphene materials, Nat. Mater, 2015, 14, 937, 942, DOI: 10.1038/nmat4367, PMID: 26259106",10.1038/nmat4367,10.1038/nmat4367,10.1038/nmat4367,48.216125
125,10.1021/jp021634q,"Jaouen, F, Marcotte, S, Dodelet, J-P, Lindbergh, G. Oxygen reduction catalysts for polymer electrolyte fuel cells from the pyrolysis of iron acetate adsorbed on various carbon supports, J. Phys. Chem. B, 2003, 107, 1376, 1386, DOI: 10.1021/jp021634q",10.1021/jp021634q,10.1021/jp021634q,10.1021/jp021634q,78.67038000000001
126,,"Dodelet, J-P. In Electrocatalysis in Fuel Cells (ed. Shao, M.) vol. 9, 271–338 (Springer London, 2013).",10.3390/catal5042115,10.3390/catal5042115,10.3390/catal5042115,17.254803
127,10.1021/acscatal.8b04609,"Holst-Olesen, K, Silvioli, L, Rossmeisl, J, Arenz, M. Enhanced oxygen reduction reaction on Fe/N/C catalyst in acetate buffer electrolyte, ACS Catal, 2019, 9, 3082, 3089, DOI: 10.1021/acscatal.8b04609",10.1021/acscatal.8b04609,10.1021/acscatal.8b04609,10.1021/acscatal.8b04609,80.16841
128,10.1021/acscatal.7b02897,"Leonard, ND. Deconvolution of utilization, site density, and turnover frequency of Fe–nitrogen–carbon oxygen reduction reaction catalysts prepared with secondary N-precursors, ACS Catal, 2018, 8, 1640, 1647, DOI: 10.1021/acscatal.7b02897",10.1021/acscatal.7b02897,10.1021/acscatal.7b02897.s001,10.1021/acscatal.7b02897,60.39
129,10.1038/ncomms8343,"Strickland, K. Highly active oxygen reduction non-platinum group metal electrocatalyst without direct metal–nitrogen coordination, Nat. Commun, 2015, 6, 7343, DOI: 10.1038/ncomms8343, PMID: 26059552",10.1038/ncomms8343,10.1038/ncomms8343,10.1038/ncomms8343,51.693165
130,10.1038/ncomms12582,"Varnell, JA. Identification of carbon-encapsulated iron nanoparticles as active species in non-precious metal oxygen reduction catalysts, Nat. Commun, 2016, 7, 12582, DOI: 10.1038/ncomms12582, PMID: 27538720",10.1038/ncomms12582,10.1038/ncomms12582,10.1038/ncomms12582,46.463745
131,10.1016/j.nanoen.2016.03.025,"Jia, Q. Spectroscopic insights into the nature of active sites in iron–nitrogen–carbon electrocatalysts for oxygen reduction in acid, Nano Energy, 2016, 29, 65, 82, DOI: 10.1016/j.nanoen.2016.03.025",10.1016/j.nanoen.2016.03.025,10.1016/j.nanoen.2016.03.025,10.1016/j.nanoen.2016.03.025,38.173603
132,10.1149/2.1041709jes,"Glibin, VP, Dodelet, J-P. Thermodynamic stability in acid media of FeN, 4-based catalytic sites used for the reaction of oxygen reduction in PEM fuel cells, J. Electrochem. Soc, 2017, 164, F948, F957, DOI: 10.1149/2.1041709jes",10.1149/2.1041709jes,10.1149/2.1041709jes,10.1149/2.1041709jes,70.24328
133,10.1021/jp002444n,"Lefèvre, M, Dodelet, JP, Bertrand, P. O, 2 reduction in PEM fuel cells: activity and active site structural information for catalysts obtained by the pyrolysis at high temperature of Fe precursors, J. Phys. Chem. B, 2000, 104, 11238, 11247, DOI: 10.1021/jp002444n",10.1021/jp002444n,10.1021/jp002444n,10.1021/jp002444n,77.44192
134,10.1016/0008-6223(95)00154-6,"Pels, JR, Kapteijn, F, Moulijn, JA, Zhu, Q, Thomas, KM. Evolution of nitrogen functionalities in carbonaceous materials during pyrolysis, Carbon, 1995, 33, 1641, 1653, DOI: 10.1016/0008-6223(95)00154-6",10.1016/0008-6223(95)00154-6,10.1016/0008-6223(95)00154-6,10.1016/0008-6223(95)00154-6,62.62242
135,10.1002/chem.201800937,"Li, H, Zhang, Z, Dou, M, Wang, F. Towards high-performance electrocatalysts for oxygen reduction: inducing atomic-level reconstruction of Fe-N, x site for atomically dispersed Fe/N-doped hierarchically porous carbon, Chem. Eur. J, 2018, 24, 8848, 8856, DOI: 10.1002/chem.201800937, PMID: 29682804",10.1002/chem.201800937,10.1002/chem.201800937,10.1002/chem.201800937,84.094826
136,10.1021/jp030349j,"Schulenburg, H. Catalysts for the oxygen reduction from heat-treated iron(iii) tetramethoxyphenylporphyrin chloride: structure and stability of active sites, J. Phys. Chem. B, 2003, 107, 9034, 9041, DOI: 10.1021/jp030349j",10.1021/jp030349j,10.1021/jp030349j,10.1021/jp030349j,55.580597
137,10.1039/c3cc40324f,"Artyushkova, K. Density functional theory calculations of XPS binding energy shift for nitrogen-containing graphene-like structures, Chem. Commun, 2013, 49, 2539, 2541, DOI: 10.1039/c3cc40324f",10.1039/c3cc40324f,10.1039/c3cc40324f,10.1039/c3cc40324f,57.652294
138,10.1021/ja00300a021,"Strauss, SH. Comparison of the molecular and electronic structures of (2,3,7,8,12,13,17,18-octaethylporphyrinato)iron(ii) and (, trans-7,8-dihydro-2,3,7,8,12,13,17,18-octaethylporphyrinato)iron(ii), J. Am. Chem. Soc, 1985, 107, 4207, 4215, DOI: 10.1021/ja00300a021",10.1021/ja00300a021,10.1021/ja00300a021,10.1021/ja00300a021,38.935852000000004
139,10.1063/1.1670618,"Dale, BW, Williams, RJP, Edwards, PR, Johnson, CE. S = 1 spin state of divalent iron. II. A Mössbauer‐effect study of phthalocyanine iron (ii), J. Chem. Phys, 1968, 49, 3445, DOI: 10.1063/1.1670618",10.1063/1.1670618,10.1063/1.1670618,10.1063/1.1670618,50.545215999999996
140,10.1021/jp802456e,"Koslowski, UI, Abs-Wurmbach, I, Fiechter, S, Bogdanoff, P. Nature of the catalytic centers of porphyrin-based electrocatalysts for the ORR: a correlation of kinetic current density with the site density of Fe−N, 4 centers, J. Phys. Chem. C, 2008, 112, 15356, 15366, DOI: 10.1021/jp802456e",10.1021/jp802456e,10.1021/jp802456e,10.1021/jp802456e,89.30835
141,10.1039/c7ee02302b,"Chenitz, R. A specific demetalation of Fe–N, 4 catalytic sites in the micropores of NC_Ar + NH, 3 is at the origin of the initial activity loss of the highly active Fe/N/C catalyst used for the reduction of oxygen in PEM fuel cells, Energy Environ. Sci, 2018, 11, 365, 382, DOI: 10.1039/C7EE02302B",10.1039/c7ee02302b,10.1039/c7ee02302b,10.1039/c7ee02302b,79.411316
142,10.1002/celc.201801302,"Wan, X. Synthesis and active site identification of Fe−N−C single-atom catalysts for the oxygen reduction reaction, ChemElectroChem, 2019, 6, 304, 315, DOI: 10.1002/celc.201801302",10.1002/celc.201801302,10.1002/celc.201801302,10.1002/celc.201801302,52.36649
143,10.1021/acsenergylett.7b00391,"Workman, MJ, Serov, A, Tsui, L, Atanassov, P, Artyushkova, K. Fe–N–C catalyst graphitic layer structure and fuel cell performance, ACS Energy Lett, 2017, 2, 1489, 1493, DOI: 10.1021/acsenergylett.7b00391",10.1021/acsenergylett.7b00391,10.1021/acsenergylett.7b00391,10.1021/acsenergylett.7b00391,69.45605
144,10.1021/jacs.8b07294,"Jiang, R. Edge-site engineering of atomically dispersed Fe–N, 4 by selective C–N bond cleavage for enhanced oxygen reduction reaction activities, J. Am. Chem. Soc, 2018, 140, 11594, 11598, DOI: 10.1021/jacs.8b07294, PMID: 30168714",10.1021/jacs.8b07294,10.1021/jacs.8b07294.s001,10.1021/jacs.8b07294,65.86440999999999
145,10.1007/s12274-017-1840-8,"Liu, D. In situ trapped high-density single metal atoms within graphene: iron-containing hybrids as representatives for efficient oxygen reduction, Nano Res, 2018, 11, 2217, 2228, DOI: 10.1007/s12274-017-1840-8",10.1007/s12274-017-1840-8,10.1007/s12274-017-1840-8,10.1007/s12274-017-1840-8,51.790783000000005
146,10.1126/science.aan2255,"Chung, HT. Direct atomic-level insight into the active sites of a high-performance PGM-free ORR catalyst, Science, 2017, 357, 479, 484, DOI: 10.1126/science.aan2255, PMID: 28774924",10.1126/science.aan2255,10.1126/science.aan2255,10.1126/science.aan2255,45.081764
147,10.1038/s41929-017-0008-y,"Fei, H. General synthesis and definitive structural identification of MN, 4C, 4 single-atom catalysts with tunable electrocatalytic activities, Nat. Catal, 2018, 1, 63, 72, DOI: 10.1038/s41929-017-0008-y",10.1038/s41929-017-0008-y,10.1038/s41929-017-0008-y,10.1038/s41929-017-0008-y,38.111263
148,10.1021/ja00817a016,"Lovecchio, FV, Gore, ES, Busch, DH. Oxidation and reduction behavior of macrocyclic complexes of nickel. Electrochemical and electron spin resonance studies, J. Am. Chem. Soc, 1974, 96, 3109, 3118, DOI: 10.1021/ja00817a016",10.1021/ja00817a016,10.1021/ja00817a016,10.1021/ja00817a016,66.694565
149,10.1016/0013-4686(82)80154-0,"van Baar, JF, van Veen, JAR, van der Eijk, JM, Peters, ThJ, de Wit, N. Electrochemical oxidation of carbon monoxide with carbon-supported group VIII metal chelates: mechanistic aspects, Electrochim. Acta, 1982, 27, 1315, 1319, DOI: 10.1016/0013-4686(82)80154-0",10.1016/0013-4686(82)80154-0,10.1016/0013-4686(82)80154-0,10.1016/0013-4686(82)80154-0,76.985405
150,10.1039/p19740000976,"Ogawa, S, Yamaguchi, T, Gotoh, N. Preparation of a conjugated tautomer of 1,14:7,8-diethenotetrapyrido-[2,1,6-de:2′,1′,6′-gh:2″,1″,6″-kl:2‴,1‴,6‴na][1,3,5,8,10,12]hexa-azacyclotetradecine and its metal derivatives, J. Chem. Soc, Perkin Trans, 1974, 1, 976, 978, DOI: 10.1039/P19740000976",10.1039/p19740000976,10.1039/p19740000976,10.1039/p19740000976,83.532234
151,10.1002/(sici)1521-3773(19990503)38:9<1255::aid-anie1255>3.0.co;2-t,"Cheng, C-C, Kuo, Y-N, Chuang, K-S, Luo, C-F, Wang, WJ. A new Co, II complex as a bulge-specific probe for, Dna. Angew. Chem. Int. Ed, 1999, 38, 1255, 1257, DOI: 10.1002/(SICI)1521-3773(19990503)38:9<1255:AID-ANIE1255>3.0.CO;2-T",10.1002/(sici)1521-3773(19990503)38:9<1255::aid-anie1255>3.0.co;2-t,10.1002/(sici)1521-3773(19990503)38:9<1255::aid-anie1255>3.0.co;2-t,10.1002/(sici)1521-3773(19990503)38:9<1255::aid-anie1255>3.0.co;2-t,64.00931
152,10.1351/pac199365071521,"Costamagna, J. Precursors of aza-macrocycles: characterization of substituted phenanthrolines and related bases. Crystal and molecular structure of dichloro-d i-n-butyl(2,2′,6,6′-bipyrimidine)tin(iv), Pure Appl. Chem, 1993, 65, 1521, 1526, DOI: 10.1351/pac199365071521",10.1351/pac199365071521,10.1351/pac199365071521,10.1351/pac199365071521,56.888819999999996
153,10.1021/jacs.5b11015,"Kramm, UI. On an easy way to prepare metal–nitrogen doped carbon with exclusive presence of MeN, 4-type sites active for the ORR, J. Am. Chem. Soc, 2016, 138, 635, 640, DOI: 10.1021/jacs.5b11015, PMID: 26651534",10.1021/jacs.5b11015,10.1021/jacs.5b11015.s001,10.1021/jacs.5b11015,61.779377000000004
154,10.1039/p19770000214,"Ogawa, S. Preparation of macrocyclic compounds by thermal dimerization of 1,10-phenanthroline derivatives, J. Chem. Soc, Perkin Trans, 1977, 1, 214, 216, DOI: 10.1039/p19770000214",10.1039/p19770000214,10.1039/p19770000214,10.1039/p19770000214,55.779003
155,,"White, A. D. Iron(III) Chloride-Dimethylformamide. In Encyclopedia of Reagents for Organic Synthesis, 10.1002/047084289X.ri058 (2001).",10.1002/047084289x,10.1002/047084289x.ri058,10.1002/047084289x.ri058,30.393478
156,10.1021/ja00470a070,"Kastner, ME, Scheidt, WR, Mashiko, T, Reed, CA. Molecular structure of diaquo-ɑ,β,ɣ,δ-tetraphenylporphinatoiron(III) perchlorate and perchlorato-ɑ,β,ɣ,δ-tetraphenylporphinatoiron(III). Two new structural types for iron(III) porphyrins, J. Am. Chem. Soc, 1978, 100, 666, 667, DOI: 10.1021/ja00470a070",10.1021/ja00470a070,10.1021/ja00470a070,10.1021/ja00470a070,58.77135
157,10.1021/ja00505a023,"Reed, CA. The missing heme spin state and a model for cytochrome c′. The mixed, S = 3/2, 5/2 intermediate spin ferric porphyrin: perchlorato(meso-tetraphenylporphinato)iron(III), J. Am. Chem. Soc, 1979, 101, 2948, 2958, DOI: 10.1021/ja00505a023",10.1021/ja00505a023,10.1021/ja00505a023,10.1021/ja00505a023,56.31052
158,10.1021/ic50169a043,"Dolphin, DH, Sams, JR, Tsin, TBik. Intermediate-spin (, S = 3/2) porphyrinatoiron(III) complexes, Inorg. Chem, 1977, 16, 711, 713, DOI: 10.1021/ic50169a043",10.1021/ic50169a043,10.1021/ic50169a043,10.1021/ic50169a043,50.39095
159,,"Sams, J. R. & Tsin, T. B. Mössbauer Spectroscopy of Iron Porphyrins. Porphyrins10.1016/B978-0-12-220104-2.50016-8 (1979).",10.1016/b978-0-12-220104-2.50016-8,10.1016/b978-0-12-220104-2.50016-8,10.1016/b978-0-12-220104-2.50016-8,44.174755
160,10.1021/ic00105a019,"Cheng, B. An unusual near-eclipsed porphyrin ring orientation in two crystalline forms of (μ-oxo)bis[(octaethylporphinato)iron(III)]. Structural and molecular mechanics studies, Inorg. Chem, 1995, 34, 102, 110, DOI: 10.1021/ic00105a019",10.1021/ic00105a019,10.1021/ic00105a019,10.1021/ic00105a019,50.538016999999996
161,10.1002/chem.201502618,"Sinha, S, Aaron, MS, Blagojevic, J, Warren, JJ. Electrocatalytic dioxygen reduction by carbon electrodes noncovalently modified with iron porphyrin complexes: enhancements from a single proton relay, Chem. Eur. J, 2015, 21, 18072, 18075, DOI: 10.1002/chem.201502618, PMID: 26459272",10.1002/chem.201502618,10.1002/chem.201502618,10.1002/chem.201502618,84.977715
162,10.1039/c7dt01174a,"Götz, R, Ly, HK, Wrzolek, P, Schwalbe, M, Weidinger, IM. Surface enhanced resonance Raman spectroscopy of iron Hangman complexes on electrodes during electrocatalytic oxygen reduction: advantages and problems of common drycast methods, Dalton Trans, 2017, 46, 13220, 13228, DOI: 10.1039/C7DT01174A, PMID: 28682383",10.1039/c7dt01174a,10.1039/c7dt01174a,10.1039/c7dt01174a,95.522316
163,10.1021/ic00160a023,"Ercolani, C, Gardini, M, Monacelli, F, Pennesi, G, Rossi, G. Interaction of (phthalocyaninato)iron(II) with molecular oxygen: synthesis and characterization of two different crystalline forms of (mu-oxo)bis[(phthalocyaninato)iron(III)], Inorg. Chem, 1983, 22, 2584, 2589, DOI: 10.1021/ic00160a023",10.1021/ic00160a023,10.1021/ic00160a023,10.1021/ic00160a023,70.564735
164,10.1021/ic00242a029,"Ercolani, C, Gardini, M, Murray, KS, Pennesi, G, Rossi, G. Crystalline isomerism in (mu-oxo)bis[(phthalocyaninato)iron(III)]: further characterization of the isomer having a linear or quasi-linear Fe-O-Fe bond system (mu-oxo(2)), Inorg. Chem, 1986, 25, 3972, 3976, DOI: 10.1021/ic00242a029",10.1021/ic00242a029,10.1021/ic00242a029,10.1021/ic00242a029,84.74531999999999
165,10.1002/anie.201804958,"Zhang, Z, Sun, J, Wang, F, Dai, L. Efficient oxygen reduction reaction (ORR) catalysts based on single iron atoms dispersed on a hierarchically structured porous carbon framework, Angew. Chem. Int. Ed, 2018, 57, 9038, 9043, DOI: 10.1002/anie.201804958",10.1002/anie.201804958,10.1002/anie.201804958,10.1002/anie.201804958,78.253
166,10.1021/ja504696r,"Lin, L, Zhu, Q, Xu, A-W. Noble-metal-free Fe–N/C catalyst for highly efficient oxygen reduction reaction under both alkaline and acidic conditions, J. Am. Chem. Soc, 2014, 136, 11027, 11033, DOI: 10.1021/ja504696r, PMID: 25058390",10.1021/ja504696r,10.1021/ja504696r,10.1021/ja504696r,71.33559
167,10.1021/ic50164a003,"Karweik, DH, Winograd, N. Nitrogen charge distributions in free-base porphyrins, metalloporphyrins, and their reduced analogs observed by x-ray photoelectron spectroscopy, Inorg. Chem, 1976, 15, 2336, 2342, DOI: 10.1021/ic50164a003",10.1021/ic50164a003,10.1021/ic50164a003,10.1021/ic50164a003,82.06634
168,10.1021/ic50197a010,"Lavallee, DK, Brace, J, Winograd, N. X-ray photoelectron spectra of N-methyltetraphenylporphyrins: evidence for a correlation of binding energies with metal-nitrogen bond distances, Inorg. Chem, 1979, 18, 1776, 1780, DOI: 10.1021/ic50197a010",10.1021/ic50197a010,10.1021/ic50197a010,10.1021/ic50197a010,77.89872
169,10.1021/ja00535a052,"Muralidharan, S, Hayes, RG. Intense satellites in the N 1s X-ray photoelectron spectra of certain metalloporphyrins, J. Am. Chem. Soc, 1980, 102, 5106, 5107, DOI: 10.1021/ja00535a052",10.1021/ja00535a052,10.1021/ja00535a052,10.1021/ja00535a052,68.52056
170,,"Nemykin, V. N. et al. Metal-free and transition-metal tetraferrocenylporphyrins part 1: synthesis, characterization, electronic structure, and conformational flexibility of neutral compounds. Dalton Trans. 4233–4246 (2008).",10.1039/b805156a,10.1039/b805156a,10.1039/b805156a,47.4649
171,10.1039/c5qi00198f,"Jia, H, Sun, Z, Jiang, D, Yang, S, Du, P. An iron porphyrin-based conjugated network wrapped around carbon nanotubes as a noble-metal-free electrocatalyst for efficient oxygen reduction reaction, Inorg. Chem. Front, 2016, 3, 821, 827, DOI: 10.1039/C5QI00198F",10.1039/c5qi00198f,10.1039/c5qi00198f,10.1039/c5qi00198f,75.79475
172,10.1063/1.440166,"Ouedraogo, GV, Benlian, D, Porte, L. X‐ray photoelectron spectroscopy of phthalocyanine compounds, J. Chem. Phys, 1980, 73, 642, DOI: 10.1063/1.440166",10.1063/1.440166,10.1063/1.440166,10.1063/1.440166,41.15044
173,10.1063/1.2212404,"Åhlund, J. The electronic structure of iron phthalocyanine probed by photoelectron and x-ray absorption spectroscopies and density functional theory calculations, J. Chem. Phys, 2006, 125, 034709, DOI: 10.1063/1.2212404",10.1063/1.2212404,10.1063/1.2212404,10.1063/1.2212404,45.81257
174,10.1002/sia.1984,"Grosvenor, AP, Kobe, BA, Biesinger, MC, McIntyre, NS. Investigation of multiplet splitting of Fe 2p XPS spectra and bonding in iron compounds, Surf. Interface Anal, 2004, 36, 1564, 1574, DOI: 10.1002/sia.1984",10.1002/sia.1984,10.1002/sia.1984,10.1002/sia.1984,70.74311
175,10.1021/acsnano.5b05984,"Jia, Q. Experimental observation of redox-induced Fe–N switching behavior as a determinant role for oxygen reduction activity, ACS Nano, 2015, 9, 12496, 12505, DOI: 10.1021/acsnano.5b05984, PMID: 26566192",10.1021/acsnano.5b05984,10.1021/acsnano.5b05984.s001,10.1021/acsnano.5b05984,52.126823
176,10.1021/jacs.6b09470,"Sa, YJ. A general approach to preferential formation of active Fe–N, x sites in Fe–N/C electrocatalysts for efficient oxygen reduction reaction, J. Am. Chem. Soc, 2016, 138, 15046, 15056, DOI: 10.1021/jacs.6b09470, PMID: 27750429",10.1021/jacs.6b09470.s001,10.1021/jacs.6b09470.s001,10.1021/jacs.6b09470,50.820744
177,10.1039/c4dt03207a,"Colomban, C. Synthesis and characterization of μ-nitrido, μ-carbido and μ-oxo dimers of iron octapropylporphyrazine, Dalton Trans, 2015, 44, 2240, 2251, DOI: 10.1039/C4DT03207A, PMID: 25519523",10.1039/c4dt03207a,10.1039/c4dt03207a,10.1039/c4dt03207a,70.68763
178,10.1021/cg030013z,"Lee, HM, Olmstead, MM, Gross, GG, Balch, AL. Cocrystallization of binuclear iron(III) porphyrins with C, 60: bending of μ-O{Fe, III(octaethylporphyrin)} and the first structure of the iron(III) octaethyloxophlorin dimer, Cryst. Growth Des, 2003, 3, 691, 697, DOI: 10.1021/cg030013z",10.1021/cg030013z,10.1021/cg030013z,10.1021/cg030013z,60.198080000000004
179,10.1021/ja964352a,"Westre, TE. A multiplet analysis of Fe K-edge 1s → 3d pre-edge features of iron complexes, J. Am. Chem. Soc, 1997, 119, 6297, 6314, DOI: 10.1021/ja964352a",10.1021/ja964352a,10.1021/ja964352a,10.1021/ja964352a,61.704075
180,10.1021/ic00207a017,"Palmer, SM. Preparation, structures, and physical properties of two products from the iodination of (phthalocyaninato)iron(II), Inorg. Chem, 1985, 24, 2040, 2046, DOI: 10.1021/ic00207a017",10.1021/ic00207a017,10.1021/ic00207a017,10.1021/ic00207a017,41.902214
181,10.1016/s0020-1693(98)00393-4,"Janczak, J, Kubiak, R, Hahn, F. A neutral molecule of I2 as a bridge for dimerization of iodine iron(III) phthalocyanine, Inorg. Chim. Acta, 1999, 287, 101, 104, DOI: 10.1016/S0020-1693(98)00393-4",10.1016/s0020-1693(98)00393-4,10.1016/s0020-1693(98)00393-4,10.1016/s0020-1693(98)00393-4,53.866867000000006
182,10.1016/j.electacta.2007.03.046,"Salimi, A, MamKhezri, H, Hallaj, R, Zandi, S. Modification of glassy carbon electrode with multi-walled carbon nanotubes and iron(III)-porphyrin film: application to chlorate, bromate and iodate detection, Electrochim. Acta, 2007, 52, 6097, 6105, DOI: 10.1016/j.electacta.2007.03.046",10.1016/j.electacta.2007.03.046,10.1016/j.electacta.2007.03.046,10.1016/j.electacta.2007.03.046,80.33288
183,10.1016/j.jpowsour.2012.05.043,"He, Q. Molecular catalysis of the oxygen reduction reaction by iron porphyrin catalysts tethered into Nafion layers: An electrochemical study in solution and a membrane-electrode-assembly study in fuel cells, J. Power Sources, 2012, 216, 67, 75, DOI: 10.1016/j.jpowsour.2012.05.043",10.1016/j.jpowsour.2012.05.043,10.1016/j.jpowsour.2012.05.043,10.1016/j.jpowsour.2012.05.043,61.56919499999999
184,10.1021/acs.jpclett.7b01126,"Alsudairi, A. Resolving the Iron Phthalocyanine Redox Transitions for ORR Catalysis in Aqueous Media, J. Phys. Chem. Lett, 2017, 8, 2881, 2886, DOI: 10.1021/acs.jpclett.7b01126, PMID: 28598166",10.1021/acs.jpclett.7b01126,10.1021/acs.jpclett.7b01126,10.1021/acs.jpclett.7b01126,54.12944
185,10.1149/1.2109667,"Zhang, L, Song, C, Zhang, J, Wang, H, Wilkinson, DP. Temperature and pH dependence of oxygen reduction catalyzed by iron fluoroporphyrin adsorbed on a graphite electrode, J. Electrochem. Soc, 2005, 152, A2421, A2426, DOI: 10.1149/1.2109667",10.1149/1.2109667,10.1149/1.2171714,10.1149/1.2109667,64.16448000000001
186,10.1021/acscentsci.9b00114,"Jackson, MN, Pegis, ML, Surendranath, Y. Graphite-conjugated acids reveal a molecular framework for proton-coupled electron transfer at electrode surfaces, ACS Cent. Sci, 2019, 5, 831, 841, PMID: 31139719",10.1021/acscentsci.9b00114,10.1021/acscentsci.9b00114,10.1021/acscentsci.9b00114,59.827065000000005
187,10.1021/acscatal.9b00588,"Luo, F. Accurate evaluation of active-site density (SD) and turnover frequency (TOF) of PGM-free metal–nitrogen-doped carbon (MNC) electrocatalysts using CO cryo adsorption, ACS Catal, 2019, 9, 4841, 4852, DOI: 10.1021/acscatal.9b00588",10.1021/acscatal.9b00588.s001,10.1021/acscatal.9b00588.s001,10.1021/acscatal.9b00588,72.54086
188,,"Asset, T, Atanassov, P. Iron-Nitrogen-Carbon Catalysts for Proton Exchange Membrane, Fuel Cells Joule, 2020, 4, 33, 44",10.1016/j.joule.2019.12.002,10.1016/j.joule.2019.12.002,10.1016/j.joule.2019.12.002,47.385796
189,10.1021/jp500781v,"Tylus, U. Elucidating oxygen reduction active sites in pyrolyzed metal–nitrogen coordinated non-precious-metal electrocatalyst systems, J. Phys. Chem. C, 2014, 118, 8999, 9008, DOI: 10.1021/jp500781v",10.1021/jp500781v,10.1021/jp500781v,10.1021/jp500781v,68.46584
190,10.1039/c6ee01160h,"Li, J. Structural and mechanistic basis for the high activity of Fe–N–C catalysts toward oxygen reduction, Energy Environ. Sci, 2016, 9, 2418, 2432, DOI: 10.1039/C6EE01160H",10.1039/c6ee01160h,10.1039/c6ee01160h,10.1039/c6ee01160h,42.74331
191,10.1016/j.elecom.2019.04.005,"Zúñiga, C. Elucidating the mechanism of the oxygen reduction reaction for pyrolyzed Fe-N-C catalysts in basic media, Electrochem. Commun, 2019, 102, 78, 82, DOI: 10.1016/j.elecom.2019.04.005",10.1016/j.elecom.2019.04.005,10.1016/j.elecom.2019.04.005,10.1016/j.elecom.2019.04.005,40.410470000000004
192,10.1021/jacs.7b10723,"Jackson, MN. Strong electronic coupling of molecular sites to graphitic electrodes via pyrazine conjugation, J. Am. Chem. Soc, 2018, 140, 1004, 1010, DOI: 10.1021/jacs.7b10723, PMID: 29216428",10.1021/jacs.7b10723.s001,10.1021/jacs.7b10723.s001,10.1021/jacs.7b10723,54.834740000000004
193,10.1021/ic00037a007,"Fitzgerald, JP, Haggerty, BS, Rheingold, AL, May, L, Brewer, GA. Iron octaethyltetraazaporphyrins: synthesis, characterization, coordination chemistry, and comparisons to related iron porphyrins and phthalocyanines, Inorg. Chem, 1992, 31, 2006, 2013, DOI: 10.1021/ic00037a007",10.1021/ic00037a007,10.1021/ic00037a007,10.1021/ic00037a007,71.52752
194,10.1021/ja410076f,"Kramm, UI, Lefèvre, M, Larouche, N, Schmeisser, D, Dodelet, J-P. Correlations between mass activity and physicochemical properties of Fe/N/C catalysts for the ORR in PEM fuel cell via, 57Fe Mössbauer spectroscopy and other techniques, J. Am. Chem. Soc, 2014, 136, 978, 985, DOI: 10.1021/ja410076f, PMID: 24345296",10.1021/ja410076f,10.1021/ja410076f,10.1021/ja410076f,83.30183000000001
195,10.1021/acsaem.8b00959,"Chen, Y, Matanovic, I, Weiler, E, Atanassov, P, Artyushkova, K. Mechanism of oxygen reduction reaction on transition metal–nitrogen–carbon catalysts: establishing the role of nitrogen-containing active sites, ACS Appl. Energy Mater, 2018, 1, 5948, 5953, DOI: 10.1021/acsaem.8b00959",10.1021/acsaem.8b00959,10.1021/acsaem.8b00959,10.1021/acsaem.8b00959,83.34463000000001
196,10.1002/anie.201604311,"Zagal, JH, Koper, MTM. Reactivity descriptors for the activity of molecular MN4 catalysts for the oxygen reduction reaction, Angew. Chem. Int. Ed, 2016, 55, 14510, 14521, DOI: 10.1002/anie.201604311",10.1002/anie.201604311,10.1002/anie.201604311,10.1002/anie.201604311,70.19791
197,10.1149/2.032206esl,"Zagal, JH. A Possible Interpretation for the high catalytic activity of heat-treated non-precious metal Nx/C catalysts for O, 2 reduction in terms of their formal potentials, Electrochem. Solid-State Lett, 2012, 15, B90, DOI: 10.1149/2.032206esl",10.1149/2.032206esl,10.1149/2.032206esl,10.1149/2.032206esl,60.797253000000005
198,10.1149/1.2904768,"Bonakdarpour, A. Impact of Loading in RRDE Experiments on Fe–N–C Catalysts: Two-or Four-Electron Oxygen Reduction, Electrochem. Solid-State Lett, 2008, 11, B105, DOI: 10.1149/1.2904768",10.1149/1.2904768,10.1149/1.2904768,10.1149/1.2904768,52.979618
199,10.1021/acscatal.5b00397,"Muthukrishnan, A, Nabae, Y, Okajima, T, Ohsaka, T. Kinetic approach to investigate the mechanistic pathways of oxygen reduction reaction on Fe-containing N-doped carbon catalysts, ACS Catal, 2015, 5, 5194, 5202, DOI: 10.1021/acscatal.5b00397",10.1021/acscatal.5b00397,10.1021/acscatal.5b00397,10.1021/acscatal.5b00397,79.627716
200,10.1021/jacs.5b00359,"Rigsby, ML, Wasylenko, DJ, Pegis, ML, Mayer, JM. Medium effects are as important as catalyst design for selectivity in electrocatalytic oxygen reduction by iron–porphyrin complexes, J. Am. Chem. Soc, 2015, 137, 4296, 4299, DOI: 10.1021/jacs.5b00359, PMID: 25798713",10.1021/jacs.5b00359,10.1021/jacs.5b00359,10.1021/jacs.5b00359,78.30011
201,10.1002/bbpc.19810850917,"van Veen, JAR. Oxygen reduction on transition-metal porphyrins in acid electrolyte I. Activity, Ber. Bunsenges. F.ür. Phys. Chem, 1981, 85, 693, 700, DOI: 10.1002/bbpc.19810850917",10.1002/bbpc.19810850917,10.1002/bbpc.19810850918,10.1002/bbpc.19810850917,45.361393
202,10.1002/bbpc.19810850918,"van Veen, JAR, Colijn, HA. Oxygen reduction on transition-metal porphyrins in acid electrolyte II. Stability, Ber. Bunsenges. F.ür. Phys. Chem, 1981, 85, 700, 704, DOI: 10.1002/bbpc.19810850918",10.1002/bbpc.19810850918,10.1002/bbpc.19810850918,10.1002/bbpc.19810850918,55.577858
203,10.1016/j.jelechem.2004.11.034,"Baranton, S, Coutanceau, C, Roux, C, Hahn, F, Léger, J-M. Oxygen reduction reaction in acid medium at iron phthalocyanine dispersed on high surface area carbon substrate: tolerance to methanol, stability and kinetics, J. Electroanal. Chem, 2005, 577, 223, 234, DOI: 10.1016/j.jelechem.2004.11.034",10.1016/j.jelechem.2004.11.034,10.1016/j.jelechem.2004.11.034,10.1016/j.jelechem.2004.11.034,75.23607
204,10.1039/c8ee01855c,"Choi, CH. The Achilles’ heel of iron-based catalysts during oxygen reduction in an acidic medium, Energy Environ. Sci, 2018, 11, 3176, 3182, DOI: 10.1039/C8EE01855C",10.1039/c8ee01855c,10.1039/c8ee01855c,10.1039/c8ee01855c,38.899464
205,10.1016/s0040-4039(03)01710-6,"Wang, W-J, Sengul, A, Luo, C-F, Kao, H-C, Cheng, Y-H. Facile one-step synthesis of a thia-bridged bis-1,10-phenanthroline macrocycle, Tetrahedron Lett, 2003, 44, 7099, 7101, DOI: 10.1016/S0040-4039(03)01710-6",10.1016/s0040-4039(03)01710-6,10.1016/s0040-4039(03)01710-6,10.1016/s0040-4039(03)01710-6,57.97996
206,10.1016/j.tetlet.2009.01.138,"Krapcho, AP, Sparapani, S, Leenstra, A, Seitz, JD. Displacement reactions of 2-chloro-and 2,9-dichloro-1,10-phenanthroline: synthesis of a sulfur-bridged bis-1,10-phenanthroline macrocycle and a 2,2′-amino-substituted-bis-1,10-phenanthroline, Tetrahedron Lett, 2009, 50, 3195, 3197, DOI: 10.1016/j.tetlet.2009.01.138",10.1016/j.tetlet.2009.01.138,10.1016/j.tetlet.2009.01.138,10.1016/j.tetlet.2009.01.138,85.85710999999999
207,10.1080/00304948.2012.697745,"Guo, HC, Zheng, RH, Jiang, HJ. Improved synthesis of 2,9-dichloro-1,10-phenanthroline, Org. Prep. Proced. Int, 2012, 44, 392, 396, DOI: 10.1080/00304948.2012.697745",10.1080/00304948.2012.697745,10.1080/00304948.2012.697745,10.1080/00304948.2012.697745,32.250873999999996
208,10.1021/om400846f,"Annibale, VT, Batcup, R, Bai, T, Hughes, SJ, Song, D. RuCp* complexes of ambidentate 4,5-diazafluorene derivatives: from linkage isomers to coordination-driven self-assembly, Organometallics, 2013, 32, 6511, 6521, DOI: 10.1021/om400846f",10.1021/om400846f,10.1021/om400846f,10.1021/om400846f,80.687164
209,,"Ogawa, S, Yamaguchi, T. & Gotoh, N. Synthesis of a novel macrocyclic compound and of its copper complex. J. Chem. Soc, Chem. Commun. 577–578 (1972).",10.1039/c39720000577,10.1039/c39720000577,10.1039/c39720000577,47.446636
210,10.1016/0022-3697(82)90028-2,"Vaishnava, PP, Montano, PA. In situ Mössbauer spectroscopic study of iron III chloride intercalated in graphite under reaction conditions, J. Phys. Chem. Solids, 1982, 43, 809, 815, DOI: 10.1016/0022-3697(82)90028-2",10.1016/0022-3697(82)90028-2,10.1016/0022-3697(82)90028-2,10.1016/0022-3697(82)90028-2,56.43221
211,,"Schlögl, R. & Jones, W. On the structure and properties of iron halide–graphite intercalates: a comparison of the reactivity of free and graphite-intercalated iron(III) chloride. J. Chem. Soc, Dalton Trans. 1283–1292 (1984).",10.1039/dt9840001283,10.1039/dt9840001283,10.1039/dt9840001283,64.89165
212,10.1515/znb-1983-0414,"Kalz, W, Homborg, H. Eisen(III)phthalocyanine: Darstellung und spektroskopische Charakterisierung von [Fe(OR), 2Pc(—2)]− (R = H, CH, 3, C, 2H, 5, (CH, 3), 2CH, (CH, 3), 3C), (FePc(—2)), 2O und FeXPc(—2) (X = F, Cl, Br, I) Z, Für. Naturforsch. B, 1983, 38, 470, 484, DOI: 10.1515/znb-1983-0414",10.1515/znb-1983-0414,10.1515/znb-1983-0414,10.1515/znb-1983-0414,84.20902
213,10.1021/jp203741y,"Ganguly, A, Sharma, S, Papakonstantinou, P, Hamilton, J. Probing the thermal deoxygenation of graphene oxide using high-resolution in situ X-ray-based spectroscopies, J. Phys. Chem. C, 2011, 115, 17009, 17019, DOI: 10.1021/jp203741y",10.1021/jp203741y,10.1021/jp203741y,10.1021/jp203741y,72.94118
214,10.1080/00268976.2014.952696,"Shao, Y. Advances in molecular quantum chemistry contained in the Q-Chem 4 program package, Mol. Phys, 2015, 113, 184, 215, DOI: 10.1080/00268976.2014.952696",10.1063/5.0004608,EXCEPTION: 'title',10.1080/00268976.2014.952696,15.644020999999999
215,10.1063/1.1626543,"Staroverov, VN, Scuseria, GE, Tao, J, Perdew, JP. Comparative assessment of a new nonempirical density functional: molecules and hydrogen-bonded complexes, J. Chem. Phys, 2003, 119, 12129, DOI: 10.1063/1.1626543",10.1063/1.1795692,10.1063/1.1795692,10.1063/1.1795692,55.619296999999996
216,10.1063/1.1677527,"Hehre, WJ, Ditchfield, R, Pople, JA. Self-consistent molecular orbital methods. XII. Further extensions of Gaussian-type basis sets for use in molecular orbital studies of organic molecules, J. Chem. Phys, 1972, 56, 2257, DOI: 10.1063/1.1677527",10.1063/1.1677527,10.1063/1.1677527,10.1063/1.1677527,70.274826
217,10.1063/1.1674902,"Ditchfield, R, Hehre, WJ, Pople, JA. Self-consistent molecular-orbital methods. IX. An extended Gaussian-type basis for molecular-orbital studies of organic molecules, J. Chem. Phys, 1971, 54, 724, DOI: 10.1063/1.1674902",10.1063/1.1674902,10.1063/1.1674902,10.1063/1.1674902,64.0841
218,10.1002/jcc.540040303,"Clark, T, Chandrasekhar, J, Spitznagel, GW, Schleyer, PVR. Efficient diffuse function-augmented basis sets for anion calculations. III. The 3-21+G basis set for first-row elements, Li-F, J. Comput. Chem, 1983, 4, 294, 301, DOI: 10.1002/jcc.540040303",10.1002/jcc.540040303,10.1002/jcc.540040303,10.1002/jcc.540040303,80.38061
219,10.1063/1.474659,"Cances, E, Mennucci, B, Tomasi, J. A new integral equation formalism for the polarizable continuum model: theoretical background and applications to isotropic and anisotropic dielectrics, J. Chem. Phys, 1997, 107, 3032, DOI: 10.1063/1.474659",10.1063/1.474659,10.1063/1.474659,10.1063/1.474659,59.590157
220,10.1107/s0021889808012016,"Momma, K, Izumi, F. VESTA: a three-dimensional visualization system for electronic and structural analysis, J. Appl. Crystallogr, 2008, 41, 653, 658, DOI: 10.1107/S0021889808012016",10.1107/s0021889808012016,10.1107/s0021889808012016,10.1107/s0021889808012016,53.604983999999995
221,10.1021/acscatal.6b01581,"Zhou, R, Zheng, Y, Jaroniec, M, Qiao, S-Z. Determination of the electron transfer number for the oxygen reduction reaction: from theory to experiment, ACS Catal, 2016, 6, 4720, 4728, DOI: 10.1021/acscatal.6b01581",10.1021/acscatal.6b01581,10.1021/acscatal.6b01581,10.1021/acscatal.6b01581,64.60155999999999
222,,"Song, C. & Zhang, J. In PEM Fuel Cell Electrocatalysts and Catalyst Layers (ed. Zhang, J.) 89–134 (Springer London, 2008).",10.1007/978-1-84800-936-3,10.1007/978-1-84800-936-3,10.1007/978-1-84800-936-3,27.121809999999996
223,10.1016/j.jsbmb.2013.05.011,"Gupta, A, Kumar, SB, Negi, AS. Current status on development of steroids as anticancer agents. J Steroid Biochem Mol Biol 2013; 137: 242–70. PMID: 23727548",10.1016/j.jsbmb.2013.05.011,10.1016/j.jsbmb.2013.05.011,10.1016/j.jsbmb.2013.05.011,38.59823
224,,"Butenandt, A, Wolff, A, Karlson, P. Über Lumi-oestron. Chem Ber 1941; 74: 1308–12.",10.1002/cber.19410740724,10.1002/cber.19410740724,10.1002/cber.19410740724,45.66581
225,,"Yaremenko, FG, Khvat, AV. A new one-pot synthesis of 17-oxo-13α-steroids of the androstane series from their 13β-analogues. Mendeleev Commun 1994; 187: 187–8.",10.1070/mc1994v004n05abeh000409,10.1070/mc1994v004n05abeh000409,10.1070/mc1994v004n05abeh000409,65.2225
226,10.1016/j.jsbmb.2011.07.009,"Ayan, D, Roy, J, Maltais, R, Poirier, D. Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity. J Steroid Biochem Mol Biol 2011; 127: 324–30. PMID: 21827856",10.1016/j.jsbmb.2011.07.009,10.1016/j.jsbmb.2011.07.009,10.1016/j.jsbmb.2011.07.009,58.314552
227,10.1021/jo000108x,"Schönecker, B, Lange, C, Kötteritzsch, M, et al. Conformational design for 13α-steroids. J Org Chem 2000; 65: 5487–97. PMID: 10970286",10.1021/jo000108x,10.1021/jo000108x,10.1021/jo000108x,44.366528
228,10.1016/j.ejmech.2014.09.051,"Kaur, R, Kaur, G, Kaur Gill, R, et al. Recent developments in tubulin polymerization inhibitors: an overview. Eur J Med Chem 2014; 87: 89–124. PMID: 25240869",10.1016/j.ejmech.2014.09.051,10.1016/j.ejmech.2014.09.051,10.1016/j.ejmech.2014.09.051,47.05773
229,10.1016/j.tcb.2018.05.001,"Steinmetz, MO, Prota, AE. Microtubule-targeting agents: strategies to hijack the cytoskeleton. Trends Cell Biol 2018; 28: 776–92. PMID: 29871823",10.1016/j.tcb.2018.05.001,10.1016/j.tcb.2018.05.001,10.1016/j.tcb.2018.05.001,45.530120000000004
230,10.1016/j.ejmech.2019.03.025,"Naaz, F, Haider, MR, Shafi, S, Yar, MS. Anti-tubulin agents of natural origin: targeting taxol, vinca, and colchicine binding domains. Eur J Med Chem 2019; 171: 310–31. PMID: 30953881",10.1016/j.ejmech.2019.03.025,10.1016/j.ejmech.2019.03.025,10.1016/j.ejmech.2019.03.025,57.796673
231,10.1016/j.ejmech.2017.11.062,"Cao, YN, Zheng, LL, Wang, D, et al. Recent advances in microtubule-stabilizing agents. Eur J Med Chem 2018; 143: 806–28. PMID: 29223097",10.1016/j.ejmech.2017.11.062,10.1016/j.ejmech.2017.11.062,10.1016/j.ejmech.2017.11.062,28.316004
232,10.1016/j.chembiol.2013.01.014,"Field, JJ, Díaz, JF, Miller, JH. The binding sites of microtubule-stabilizing agents. Chem Biol 2013; 20: 301–15. PMID: 23521789",10.1016/j.chembiol.2013.01.014,10.1016/j.chembiol.2013.01.014,10.1016/j.chembiol.2013.01.014,31.877975
233,10.4155/fmc-2017-0100,"Li, W, Sun, H, Xu, S, et al. Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med Chem 2017; 9: 1765–94. PMID: 28929799",10.4155/fmc-2017-0100,10.4155/fmc-2017-0100,10.4155/fmc-2017-0100,43.321632
234,10.1021/ml200149g,"Beale, TM, Allwood, DM, Bender, A, et al. A-ring dihalogenation increases the cellular activity of combretastatin templated tetrazoles. ACS Med Chem Lett 2012; 3: 177–81. PMID: 24900453",10.1021/ml200149g,10.1021/ml200149g,10.1021/ml200149g,41.868633
235,,"Liang, L, Astruc, D. The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) “click” reaction and its applications. An overview. Coord Chem Rev 2011; 255: 2933–45.",10.1016/j.ccr.2011.06.028,10.1016/j.ccr.2011.06.028,10.1016/j.ccr.2011.06.028,50.145171999999995
236,,"Szabó, J, Jerkovics, N, Schneider, G, et al. Synthesis and in vitro antiproliferative evaluation of C-13 epimers of triazolyl-d-secoestrone alcohols: the first potent 13α-d-secoestrone derivative. Molecules 2016; 21: 611–24.",10.3390/molecules21050611,10.3390/molecules21050611,10.3390/molecules21050611,74.2808
237,10.1016/j.jsbmb.2016.06.013,"Bózsity, N, Minorics, R, Szabó, J, et al. Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility. J Steroid Biochem Mol Biol 2017; 165: 247–57. PMID: 27363663",10.1016/j.jsbmb.2016.06.013,10.1016/j.jsbmb.2016.06.013,10.1016/j.jsbmb.2016.06.013,53.199535
238,10.1016/j.steroids.2016.05.010,"Szabó, J, Pataki, Z, Wölfling, J, et al. Synthesis and biological evaluation of 13α-estrone derivatives as potential antiproliferative agents. Steroids 2016; 113: 14–21. PMID: 27263437",10.1016/j.steroids.2016.05.010,10.1016/j.steroids.2016.05.010,10.1016/j.steroids.2016.05.010,50.91751
239,10.1080/14756366.2018.1490731,"Bacsa, I, Herman, BE, Jójárt, R, et al. Synthesis and structure-activity relationships of 2-and/or 4-halogenated 13β-and 13α-estrone derivatives as enzyme inhibitors of estrogen biosynthesis. J Enzyme Inhib Med Chem 2018; 33: 1271–82. PMID: 30230387",10.1080/14756366.2018.1490731,10.1080/14756366.2018.1490731,10.1080/14756366.2018.1490731,57.64403000000001
240,10.3762/bjoc.14.262,"Jójárt, R, Pécsy, S, Keglevich, G, et al. Pd-catalyzed microwave-assisted synthesis of phosphonated 13α-estrones as potential OATP2B1, 17β-HSD1 and/or STS inhibitors. Beilstein J Org Chem 2018; 14: 2838–45. PMID: 30498534",10.3762/bjoc.14.262,10.3762/bjoc.14.262,10.3762/bjoc.14.262,78.24933
241,,"Hirao, T, Masunaga, T, Ohshiro, Y, Agawa, T. Stereoselective synthesis of vinylphosphonate. Tetrahedron Lett 1980; 21: 3595–8.",10.1016/0040-4039(80)80245-0,10.1016/0040-4039(80)80245-0,10.1016/0040-4039(80)80245-0,44.423203
242,,"Keglevich, G, Jablonkai, E, László, BB. A “green” variation of the Hirao reaction: the P-C coupling of diethyl phosphite, alkyl phenyl-H-phosphinates and secondary phosphine oxides with bromoarenes using a P-ligand-free Pd(OAc) 2 catalyst under micro-wave and solvent-free conditions. RSC Adv 2014; 4: 22808–16.",10.1039/c4ra03292f,10.1039/c4ra03292f,10.1039/c4ra03292f,84.560074
243,10.1021/acs.joc.6b00220,"Dziuganowska, ZA, Ślepokura, K, Volle, JN, et al. Structural analogues of Selfotel (CGS-19755). J Org Chem 2016; 81: 4947–54. PMID: 27187758",10.1021/acs.joc.6b00220,10.1021/acs.joc.6b00220,10.1021/acs.joc.6b00220,42.9514
244,10.1002/adsc.201700895,"Keglevich, G, Henyecz, R, Mucsi, Z, Kiss, NZ. The palladium acetate-catalyzed microwave-assisted Hirao reaction without an added phosphorus ligand as a “green” protocol: a quantum chemical study on the mechanism. Adv Synth Catal 2017; 359: 4322–31. PMID: 29399016",10.1002/adsc.201700895,10.1002/adsc.201700895,10.1002/adsc.201700895,76.32399000000001
245,10.1016/j.dmpk.2014.10.005,"Matsumoto, J, Ariyoshi, N, Sakakibara, M, et al. Organic anion transporting polypeptide 2B1 expression correlates with uptake of estrone-3-sulfate and cell proliferation in estrogen receptor-positive breast cancer cells. Drug Metab Pharmacokinet 2015; 30: 133–41. PMID: 25857231",10.1016/j.dmpk.2014.10.005,10.1016/j.dmpk.2014.10.005,10.1016/j.dmpk.2014.10.005,54.37602
246,10.1124/jpet.112.192344,"Banerjee, N, Allen, C, Bendayan, R. Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells. J Pharmacol Exp Ther 2012; 342: 510–09. PMID: 22588260",10.1124/jpet.112.192344,10.1124/jpet.112.192344,10.1124/jpet.112.192344,70.06253000000001
247,10.1016/j.steroids.2014.05.015,"Mernyák, E, Szabó, J, Bacsa, I, et al. Syntheses and antiproliferative effects of D-homo-and D-secoestrones. Steroids 2014; 87: 128–36. PMID: 24928727",10.1016/j.steroids.2014.05.015,10.1016/j.steroids.2014.05.015,10.1016/j.steroids.2014.05.015,43.62153
248,10.2174/092986712802430072,"Peyrat, J-F, Brion, J-D, Alami, M. Synthetic 2-methoxyestradiol derivatives: structure-activity relationships. Curr Med Chem 2012; 19: 4142–56. PMID: 22709003",10.2174/092986712802430072,10.2174/092986712802430072,10.2174/092986712802430072,43.43199
249,10.1016/0022-1759(83)90303-4,"Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and citotoxicity assays. J Immunol Methods 1983; 65: 55–63. PMID: 6606682",10.1016/0022-1759(83)90303-4,10.1016/0022-1759(83)90303-4,10.1016/0022-1759(83)90303-4,43.260174
251,10.1021/jm030644s,"Halgren, TA, Murphy, RB, Friesner, RA, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 2004; 47: 1750–9. PMID: 15027866",10.1021/jm030644s,10.1021/jm030644s,10.1021/jm030644s,49.011375
253,10.1093/nar/28.1.235,"Berman, HM, Westbrook, J, Feng, Z, et al. The protein data bank. Protein Data Bank Nucleic Acids Res 2000; 28: 235–42. PMID: 10592235",10.1093/nar/28.1.235,10.2210/rcsb_pdb/pdb-cit-anal-2017,10.1093/nar/28.1.235,30.706131
254,,"Sastry, GM, Adzhigirey, M, Day, T, et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aid Mol Des 2013; 27: 221–34.",10.1007/s10822-013-9644-8,10.1007/s10822-013-9644-8,10.1007/s10822-013-9644-8,50.207638
256,,"Bowers, KJ, Chow, E, Xu, H, et al, Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, FL, 2006, November 11–17.",10.1145/1188455.1188544,10.1145/1188455.1188544,10.1145/1188455.1188544,29.988971999999997
258,10.1021/acs.jctc.5b00864,"Harder, E, Damm, W, Maple, J, et al. OPLS3: a force field providing broad coverage of drug-like small molecules and proteins. J Chem Theory Comput 2016; 12: 281–96. PMID: 26584231",10.1021/acs.jctc.5b00864.s001,10.1021/acs.jctc.5b00864.s001,10.1021/acs.jctc.5b00864,45.003685
259,,"Hoover, WG. Canonical dynamics: equilibrium phase-space distributions. Phys Rev A 1985; 31: 1695–7.",10.1103/physreva.31.1695,10.1103/physreva.31.1695,10.1103/physreva.31.1695,35.821815
260,10.1038/nrd.2018.21,"Ferguson, FM, Gray, NS. Kinase inhibitors: the road ahead. Nat Rev Drug Discov 2018; 17: 353–77. PMID: 29545548",10.1038/nrd.2018.21,10.1038/nrd.2018.21,10.1038/nrd.2018.21,38.868206
261,10.1186/s12943-018-0804-2,"Bhullar, KS, Lagaron, NO, McGowan, EM, et al. Kinase-targeted cancer therapies: progress, challenges and future directions. Mol Cancer 2018; 17: 48. PMID: 29455673",10.1186/s12943-018-0804-2,10.1186/s12943-018-0804-2,10.1186/s12943-018-0804-2,35.566353
262,10.1016/j.tips.2015.04.005,"Wu, P, Nielsen, TE, Clausen, MH. FDA-approved small-molecule kinase inhibitors. Trends Pharmacol Sci 2015; 36: 422–39. PMID: 25975227",10.1016/j.tips.2015.04.005,10.1016/j.tips.2015.04.005,10.1016/j.tips.2015.04.005,38.673218
263,10.1016/j.phrs.2019.104609,"Roskoski, R, Jr. Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update. Pharmacol Res 2020; 152: 104609. PMID: 31862477",10.1016/j.phrs.2019.104609,10.1016/j.phrs.2019.104609,10.1016/j.phrs.2019.104609,50.3883
264,10.1016/j.currproblcancer.2013.06.001,"Jeong, W, Doroshow, JH, Kummar, S. United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies. Curr Probl Cancer 2013; 37: 110–44. PMID: 23972982",10.1016/j.currproblcancer.2013.06.001,10.1016/j.currproblcancer.2013.06.001,10.1016/j.currproblcancer.2013.06.001,49.336009999999995
265,10.1021/acs.jmedchem.8b01469,"Tadesse, S, Caldon, EC, Tilley, W, Wang, S. Cyclin-dependent kinase 2 inhibitors in cancer therapy: an update. J Med Chem 2019; 62: 4233–51. PMID: 30543440",10.1021/acs.jmedchem.8b01469,10.1021/acs.jmedchem.8b01469,10.1021/acs.jmedchem.8b01469,48.761112
267,10.1073/pnas.90.3.1112,"Keyomarsi, K, Pardee, AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci U S A 1993; 90: 1112–6. PMID: 8430082",10.1073/pnas.90.3.1112,10.1073/pnas.90.3.1112,10.1073/pnas.90.3.1112,43.453959999999995
268,10.18632/oncotarget.4600,"Yang, L, Fang, D, Chen, H, et al. Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression. Oncotarget 2015; 6: 20801–12. PMID: 26204491",10.18632/oncotarget.4600,10.18632/oncotarget.4600,10.18632/oncotarget.4600,51.716736
269,10.3892/ijo.13.2.233,"Yamamoto, H, Monden, T, Miyoshi, H, et al. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells. Int J Oncol 1998; 13: 233–9. PMID: 9664116",10.3892/ijo.13.2.233,10.3892/ijo.13.2.233,10.3892/ijo.13.2.233,68.10514
270,10.1016/j.tranon.2016.08.007,"Wang, J, Yang, T, Xu, G, et al. Cyclin-dependent kinase 2 promotes tumor proliferation and induces radio resistance in glioblastoma. Transl Oncol 2016; 9: 548–56. PMID: 27863310",10.1016/j.tranon.2016.08.007,10.1016/j.tranon.2016.08.007,10.1016/j.tranon.2016.08.007,39.194725
271,10.4161/cc.6.23.4994,"Faber, AC, Chiles, TC. Inhibition of cyclin-dependent kinase-2 induces apoptosis in human diffuse large B-cell lymphomas. Cell Cycle 2007; 6: 2982–9. PMID: 18156799",10.4161/cc.6.23.4994,10.4161/cc.6.23.4994,10.4161/cc.6.23.4994,54.368687
272,10.2217/fon-2017-0561,"Yin, X, Yu, J, Zhou, Y, et al. Identification of CDK2 as a novel target in treatment of prostate cancer. Future Oncol 2018; 14: 709–18. PMID: 29323532",10.2217/fon-2017-0561,10.2217/fon-2017-0561,10.2217/fon-2017-0561,33.294888
273,10.3389/fonc.2018.00303,"Lin, ZP, Zhu, YL, Ratner, ES. Targeting cyclin-dependent kinases for treatment of gynecologic cancers. Front Oncol 2018; 8: 303. PMID: 30135856",10.3389/fonc.2018.00303,10.3389/fonc.2018.00303,10.3389/fonc.2018.00303,41.508858000000004
275,10.1021/jm800382h,"Wyatt, PG, Woodhead, AJ, Berdini, V, et al. Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a novel cyclin dependent kinase inhibitor using fragment-based X-ray crystallography and structure based drug design. J Med Chem 2008; 51: 4986–99. PMID: 18656911",10.2210/pdb2vta/pdb,10.2210/pdb2vtp/pdb,10.2210/pdb2vtp/pdb,53.521126
276,10.1080/10428194.2016.1239259,"Seftel, MD, Kuruvilla, J, Kouroukis, T, et al. The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group. Leuk Lymphoma 2017; 58: 1358–65. PMID: 27750483",10.1080/10428194.2016.1239259,10.1080/10428194.2016.1239259,10.1080/10428194.2016.1239259,57.077534
277,10.1016/j.ejmech.2020.112073,"Cheng, C, Yun, F, Ullah, S, Yuan, Q. Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors with potent in vitro and in vivo anticancer activity. Eur J Med Chem 2020; 189: 112073. PMID: 31991336",10.1016/j.ejmech.2020.112073,10.1016/j.ejmech.2020.112073,10.1016/j.ejmech.2020.112073,65.59123000000001
278,10.1021/jm0103256,"Honma, T, Hayashi, K, Aoyama, T, et al. Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design. J Med Chem 2001; 44: 4615–27. PMID: 11741479",10.1021/jm0103256,10.1021/jm0103256,10.1021/jm0103256,40.666046
279,10.1158/0008-5472.can-05-2507,"Payton, M, Chung, G, Yakowec, P, et al. Discovery and evaluation of dual CDK1 and CDK2 inhibitors. Cancer Res 2006; 66: 4299–308. PMID: 16618755",10.1158/0008-5472.can-05-2507,10.1158/0008-5472.can-05-2507,10.1158/0008-5472.can-05-2507,35.507607
280,10.3109/14756366.2015.1057716,"Wróbel, TM, Kiełbus, M, Kaczor, AA, et al. Discovery of nitroaryl urea derivatives with antiproliferative properties. J Enzyme Inhib Med Chem 2016; 31: 608–18. PMID: 26114307",10.3109/14756366.2015.1057716,10.3109/14756366.2015.1057716,10.3109/14756366.2015.1057716,38.000415999999994
281,10.1021/acschembio.5b00398,"Alexander, LT, Möbitz, H, Drueckes, P, et al. Type II inhibitors targeting CDK2. ACS Chem Biol 2015; 10: 2116–25. PMID: 26158339",10.1021/acschembio.5b00398,10.1021/acschembio.5b00398,10.1021/acschembio.5b00398,38.062763000000004
282,10.1016/j.bioorg.2014.01.001,"Gouda, AM, Abdelazeem, AH, Arafa, e-SA, Abdellatif, KR. Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents. Bioorg Chem 2014; 53: 1–7. PMID: 24462996",10.1016/j.bioorg.2014.01.001,10.1016/j.bioorg.2014.01.001,10.1016/j.bioorg.2014.01.001,50.125893
283,10.1016/j.bmc.2017.08.039,"Gouda, AM, Abdelazeem, AH, Omar, HA, et al. Pyrrolizines: design, synthesis, anticancer evaluation and investigation of the potential mechanism of action. Bioorg Med Chem 2017; 25: 5637–51. PMID: 28916158",10.1016/j.bmc.2017.08.039,10.1016/j.bmc.2017.08.039,10.1016/j.bmc.2017.08.039,40.820698
284,10.1016/j.ejmech.2019.111780,"Shawky, AM, Abourehab, MAS, Abdalla, AN, Gouda, AM. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: design, synthesis and investigation of cytotoxicity and anti-inflammatory potency. Eur J Med Chem 2020; 185: 111780. PMID: 31655429",10.1016/j.ejmech.2019.111780,10.1016/j.ejmech.2019.111780,10.1016/j.ejmech.2019.111780,65.832
285,10.1016/j.ejmech.2019.01.003,"Cheng, W, Yang, Z, Wang, S, et al. Recent development of CDK inhibitors: an overview of CDK/inhibitor co-crystal structures. Eur J Med Chem 2019; 164: 615–39. PMID: 30639897",10.1016/j.ejmech.2019.01.003,10.1016/j.ejmech.2019.01.003,10.1016/j.ejmech.2019.01.003,42.89363
286,10.1016/j.ejmech.2017.07.067,"Tutone, M, Almerico, AM. Recent advances on CDK inhibitors: an insight by means of in silico methods. Eur J Med Chem 2017; 142: 300–15. PMID: 28802482",10.1016/j.ejmech.2017.07.067,10.1016/j.ejmech.2017.07.067,10.1016/j.ejmech.2017.07.067,47.356358
287,,"Ece, A, Sevin, F. The discovery of potential cyclin A/CDK2 inhibitors: a combination of 3D QSAR pharmacophore modeling, virtual screening, and molecular docking studies. Med Chem Res 2013; 22: 5832–43.",10.1007/s00044-013-0571-y,10.1007/s00044-013-0571-y,10.1007/s00044-013-0571-y,64.648315
288,,"Mohammad, T, Batra, S, Dahiya, R, et al. Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy. Molecules 2019; 24: 4589.",10.3390/molecules24244589,10.3390/molecules24244589,10.3390/molecules24244589,47.484028
289,10.1016/j.ejmech.2015.04.032,"Nakanishi, I, Murata, K, Nagata, N, et al. Identification of protein kinase CK2 inhibitors using solvent dipole ordering virtual screening. Eur J Med Chem 2015; 96: 396–404. PMID: 25912672",10.1016/j.ejmech.2015.04.032,10.1016/j.ejmech.2015.04.032,10.1016/j.ejmech.2015.04.032,38.206177000000004
290,10.1021/jm050468i,"Zhang, Q, Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. J Med Chem 2006; 49: 1536–48. PMID: 16509572",10.1021/jm050468i,10.1021/jm050468i,10.1021/jm050468i,63.875572
291,10.1080/14756366.2019.1693702,"Liang, J-W, Wang, M-Y, Wang, S, et al. Identification of novel CDK2 inhibitors by a multistage virtual screening method based on SVM, pharmacophore and docking model. J Enzyme Inhib Med Chem 2020; 35: 235–44. PMID: 31760818",10.1080/14756366.2019.1693702,10.1080/14756366.2019.1693702,10.1080/14756366.2019.1693702,45.9768
292,10.1007/s00894-012-1528-7,"Poulsen, A, William, A, Blanchard, S, et al. Structure-based design of nitrogen-linked macrocyclic kinase inhibitors leading to the clinical candidate SB1317/TG02, a potent inhibitor of cyclin dependant kinases (CDKs), Janus kinase 2 (JAK2), and Fms-like tyrosine kinase-3 (FLT3). J Mol Model 2013; 19: 119–30. PMID: 22820730",10.1007/s00894-012-1528-7,10.1007/s00894-012-1528-7,10.1007/s00894-012-1528-7,80.75371
293,10.1007/978-1-60761-839-3_11,"Horvath, D. Pharmacophore-based virtual screening. Methods Mol Biol 2011; 672: 261–98. PMID: 20838973",10.1007/978-1-60761-839-3_11,10.1007/978-1-60761-839-3_11,10.1007/978-1-60761-839-3_11,23.23046
294,10.1016/j.bmcl.2015.08.050,"Hu, Y, Li, S, Liu, F, et al. Discovery of novel nonpeptide allosteric inhibitors interrupting the interaction of CDK2/cyclin A3 by virtual screening and bioassays. Bioorg Med Chem Lett 2015; 25: 4069–73. PMID: 26316466",10.1016/j.bmcl.2015.08.050,10.1016/j.bmcl.2015.08.050,10.1016/j.bmcl.2015.08.050,54.0982
295,10.1093/nar/gkw287,"Sunseri, J, Koes, DR. Pharmit: interactive exploration of chemical space. Nucleic Acids Res 2016; 44: W442–8. PMID: 27095195",10.1093/nar/gkw287,10.1093/nar/gkw287,10.1093/nar/gkw287,52.89154
296,,"Gouda, AM, Ali, HI, Almalki, WH, Azim, MA, et al. Design, synthesis, and biological evaluation of some novel pyrrolizine derivatives as COX inhibitors with anti-inflammatory/analgesic activities and low ulcerogenic liability. Molecules 2016; 21: 201.",10.3390/molecules21020201,10.3390/molecules21020201,10.3390/molecules21020201,67.58546
297,10.1016/j.bioorg.2019.103371,"Attalah, KM, Abdalla, AN, Aslam, A, Ahmed, M, et al. Ethyl benzoate bearing pyrrolizine/indolizine moieties: design, synthesis and biological evaluation of anti-inflammatory and cytotoxic activities. Bioorg Chem 2020; 94: 103371. PMID: 31708230",10.1016/j.bioorg.2019.103371,10.1016/j.bioorg.2019.103371,10.1016/j.bioorg.2019.103371,63.6268
298,10.2478/acph-2018-0026,"Gouda, AM, Abdelazeem, AH, Abdalla, AN, Ahmed, M. Pyrrolizine-5-carboxamides: exploring the impact of various substituents on anti-inflammatory and anticancer activities. Acta Pharm 2018; 68: 251–73. PMID: 31259695",10.2478/acph-2018-0026,10.2478/acph-2018-0026,10.2478/acph-2018-0026,57.056580000000004
299,,"Belal, A, Gouda, AM, Ahmed, AS, Abdel Gawad, NM. Synthesis of novel indolizine, diazepinoindolizine and pyrimidoindolizine derivatives as potent and selective anticancer agents. Res Chem Intermed 2015; 41: 9687–701.",10.1007/s11164-015-1958-9,10.1007/s11164-015-1958-9,10.1007/s11164-015-1958-9,71.91985
301,10.1016/j.ejmech.2018.04.029,"Malki, WH, Gouda, AM, Ali, HEA, et al. Structural-based design, synthesis, and antitumor activity of novel alloxazine analogues with potential selective kinase inhibition. Eur J Med Chem 2018; 152: 31–52. PMID: 29684708",10.1016/j.ejmech.2018.04.029,10.1016/j.ejmech.2018.04.029,10.1016/j.ejmech.2018.04.029,42.823741999999996
302,10.1016/j.jsps.2019.04.003,"Alkahtani, HM, Alanazi, MM, Aleanizy, FS, et al. Synthesis, anticancer, apoptosis-inducing activities and EGFR and VEGFR2 assay mechanistic studies of 5,5-diphenylimidazolidine-2,4-dione derivatives: molecular docking studies. Saudi Pharm J 2019; 27: 682–93. PMID: 31297023",10.1016/j.jsps.2019.04.003,10.1016/j.jsps.2019.04.003,10.1016/j.jsps.2019.04.003,56.861637
303,,"Abdalla, AN, Shaheen, U, Abdallah, QMA, et al. Proapoptotic activity of Achillea membranacea essential oil and its major constituent 1,8-cineole against A2780 ovarian cancer cells. Molecules 2020; 25: 1582.",10.3390/molecules25071582,10.3390/molecules25071582,10.3390/molecules25071582,59.21951
304,10.1016/j.bmc.2018.05.024,"Wang, Y, Chen, Y, Cheng, X, et al. Design, synthesis and biological evaluation of pyrimidine derivatives as novel CDK2 inhibitors that induce apoptosis and cell cycle arrest in breast cancer cells. Bioorg Med Chem 2018; 26: 3491–501. PMID: 29853338",10.1016/j.bmc.2018.05.024,10.1016/j.bmc.2018.05.024,10.1016/j.bmc.2018.05.024,52.64069
305,10.1002/jcc.21256,"Morris, GM, Huey, R, Lindstrom, W, et al. AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 2009; 30: 2785–91. PMID: 19399780",10.1002/jcc.21256,10.1002/jcc.21256,10.1002/jcc.21256,48.803078
306,,"Gouda, AM, Almalki, FA. Carprofen: a theoretical mechanistic study to investigate the impact of hydrophobic interactions of alkyl groups on modulation of COX-1/2 binding selectivity. SN Appl Sci 2019; 1: 332.",10.1007/s42452-019-0335-5,10.1007/s42452-019-0335-5,10.1007/s42452-019-0335-5,59.914852
308,,"Attallah, KM, Gouda, AM, Ibrahim, IT, Abouzeid, L. Design, synthesis, 99mTc labeling, and biological evaluation of a novel pyrrolizine derivative as potential anti-inflammatory agent. Radiochemistry 2017; 59: 630–8.",10.1134/s10663622170600121,10.1134/s10663622170600121,10.1134/s10663622170600121,64.25371
310,10.1021/jm0600388,"Lu, H, Schulze-Gahmen, U. Toward understanding the structural basis of cyclin-dependent kinase 6 specific inhibition. J Med Chem 2006; 49: 3826–31. PMID: 16789739",10.1021/jm0600388,10.1021/jm0600388,10.1021/jm0600388,53.382698
311,10.1021/cb2004516,"Baumli, S, Hole, AJ, Noble, ME, Endicott, JA. The CDK9 C-helix exhibits conformational plasticity that may explain the selectivity of CAN508. ACS Chem Biol 2012; 7: 811–6. PMID: 22292676",10.1021/cb2004516,10.1021/cb2004516,10.1021/cb2004516,64.71679
312,10.1038/srep42717,"Daina, A, Michielin, O, Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep 2017; 7: 42717. PMID: 28256516",10.1038/srep42717,10.1038/srep42717,10.1038/srep42717,69.10425
313,,"Lipinski, CA, Lombardo, F, Dominy, BW, Feeney, PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997; 23: 3–25.",10.1016/s0169-409x(96)00423-1,10.1016/s0169-409x(96)00423-1,10.1016/s0169-409x(96)00423-1,52.429028
314,10.1023/a:1020444330011,"Zhao, YH, Abraham, MH, Le, J, et al. Rate-limited steps of human oral absorption and QSAR studies. Pharm Res 2002; 19: 1446–57. PMID: 12425461",10.1023/a:1020444330011,10.1002/jps.1031,10.1023/a:1020444330011,15.60845
315,10.1038/nrd842,"Atkins, JH, Gershell, LJ. Selective anticancer drugs. Nat Rev Drug Discov 2002; 1: 491–2. PMID: 12120255",10.1038/nrd842,10.1038/nrd842,10.1038/nrd842,41.210453
316,10.1038/nrd4504,"Asghar, U, Witkiewicz, AK, Turner, NC, Knudsen, ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov 2015; 14: 130–46. PMID: 25633797",10.1038/nrd4504,10.1038/nrd4504,10.1038/nrd4504,52.15012
318,10.1016/s1359-6446(01)01712-3,"Li, AP. Screening for human ADME/Tox drug properties in drug discovery. Drug Discov Today 2001; 6: 357–66. PMID: 11267922",10.1016/s1359-6446(01)01712-3,10.1016/s1359-6446(01)01712-3,10.1016/s1359-6446(01)01712-3,43.866875
319,10.2174/156802611794480927,"Gleeson, MP, Hersey, A, Hannongbua, S. In-silico ADME models: a general assessment of their utility in drug discovery applications. Curr Top Med Chem 2011; 11: 358–81. PMID: 21320065",10.2174/156802611794480927,10.2174/156802611794480927,10.2174/156802611794480927,50.760536
320,10.2174/1389200218666170316094104,"Yan, G, Wang, X, Chen, Z, et al. In-silico ADME studies for new drug discovery: from chemical compounds to Chinese herbal medicines. Curr Drug Metab 2017; 18: 535–9. PMID: 28302029",10.2174/1389200218666170316094104,10.2174/1389200218666170316094104,10.2174/1389200218666170316094104,41.582446999999995
321,10.1016/s0140-6736(18)32203-7,"GBD 2017 Causes of Death Collaborators Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 10; 392(10159): 1736–8. PMID: 30496103",10.3410/f.725286838.793544011,10.1097/01.ogx.0000511935.64476.66,10.1016/s0140-6736(18)32203-7,46.42066
322,10.1002/ccd.1810160103,"Campeau, L. Percutaneous radial artery approach for coronary angiography. Cathet Cardiovasc Diagn. 1989 janv; 16(1): 3–7. PMID: 2912567",10.1002/ccd.1810160103,10.1002/ccd.1810160103,10.1002/ccd.1810160103,43.114906
324,,"Babunashvili, A, Dundua, D. Recanalization and reuse of early occluded radial artery within 6 days after previous transradial diagnostic procedure. Catheterization Cardiovasc Interventions. 2011; 77(4): 530–536.",10.1002/ccd.22846,10.1002/ccd.22846,10.1002/ccd.22846,65.71699
325,,"Kiemeneij, F. Left distal transradial access in the anatomical snuffbox for coronary angiography (ldTRA) and interventions (ldTRI) [Internet]. EuroIntervention. [ citéd 2019 10 12]. Disponible sur: https://eurointervention.pcronline.com/article/left-distal-transradial-access-in-the-anatomical-snuffbox-for-coronary-angiography-ldtra-and-interventions-ldtri",10.4244/eij-d-17-00079,10.4244/eij-d-17-00079,10.4244/eij-d-17-00079,61.331703000000005
326,,"Vefalı V, Sarıçam E. The Comparison of Traditional Radial Access and Novel Distal Radial Access for Cardiac Catheterization. Cardiovasc Revasc Med. 2020 Apr;21(4):496–500.",10.1016/j.carrev.2019.07.001,10.1016/j.carrev.2019.07.001,10.1016/j.carrev.2019.07.001,57.272156
327,,"Koutouzis, M, Kontopodis, E, Tassopoulos, A, et al. Distal versus traditional radial approach for coronary angiography. Cardiovasc Revascularization Med. 2019 août 1; 20(8): 678–680.",10.1016/j.carrev.2018.09.018,10.1016/j.carrev.2018.09.018,10.1016/j.carrev.2018.09.018,41.727394
328,10.1016/j.carrev.2020.03.020.,"Hamandi, M, Saad, M, Hasan, R, et al. Distal versus conventional transradial artery access for coronary angiography and intervention: A meta-analysis. Cardiovasc Revasc Med. 2020 Mars 14 DOI: DOI: 10.1016/j.carrev.2020.03.020.",10.1016/j.carrev.2020.03.020,10.1016/j.carrev.2020.03.020,10.1016/j.carrev.2020.03.020,42.292408
329,,"Amin, MR, Singha, CK, Banerjee, SK, et al. Comparison of distal transradial in the anatomical snuffbox versus conventional transradial access for coronary angiography and intervention-an experience in 100 cases. Univ Heart J. 2017; 13(2): 40–45.",10.3329/uhj.v13i2.37657,10.3329/uhj.v13i2.37657,10.3329/uhj.v13i2.37657,62.040436
330,,"Gajurel, RM, Sahi, R, Shrestha, H, et al. Initial experience on anatomical snuff box approach for coronary angiogram & percutaneous coronary intervention in a tertiary care center Nepal. World J Cardiovasc Dis. 2018 déc 28; 08(12): 578.",10.4236/wjcd.2018.812057,10.4236/wjcd.2018.812057,10.4236/wjcd.2018.812057,62.562008
331,10.7759/cureus.7201,"Nairoukh, Z, Jahangir, S, Adjepong, D, et al. Distal radial artery access: the future of cardiovascular intervention. Cureus. 2020 3 7; 12(3): e7201. PMID: 32269880",10.7759/cureus.7201,10.7759/cureus.7201,10.7759/cureus.7201,48.84918
332,,"Coomes, EA, Haghbayan, H, Cheema, AN. Distal transradial access for cardiac catheterization: a systematic scoping review. Catheterization Cardiovasc Interventions. citéd 2020 janv 30.",10.1002/ccd.28623,10.1002/ccd.28623,10.1002/ccd.28623,54.87818000000001
333,10.4244/eij-d-18-00635,"Lee, J-W, Park, SW, Son, J-W, et al. Real-world experience of the left distal transradial approach for coronary angiography and percutaneous coronary intervention: a prospective observational study (LeDRA). EuroIntervention. 2018 10 12; 14(9): e995–1003. PMID: 30222122",10.4244/eij-d-18-00635,10.4244/eij-d-18-00635,10.4244/eij-d-18-00635,59.224430000000005
334,10.1111/joic.12559,"Coughlan, JJ, Zebrauskaite, A, Arnous, S, et al. Left distal trans-radial access facilitates earlier discharge post-coronary angiography. J Interv Cardiol. 2018 déc; 31(6): 964–968. PMID: 30187577",10.1111/joic.12559,10.1111/joic.12559,10.1111/joic.12559,61.55079
335,10.5114/aic.2019.83771,"Wretowski, D, Krakowian, M, Łabyk, A, et al. Very distal transradial approach (VITRO) for coronary interventions. Postepy Kardiol Interwencyjnej. 2019; 15(1): 42–45. PMID: 31043983",10.5114/aic.2019.83771,10.5114/aic.2019.83771,10.5114/aic.2019.83771,49.488686
336,,"Kühn, AL, de Macedo Rodrigues, K, Singh, J, et al. Distal radial access in the anatomical snuffbox for neurointerventions: a feasibility, safety, and proof-of-concept study. J Neurointerv Surg. 2020 janv 8; 12(8): 798–801.",10.1136/neurintsurg-2019-015604,10.1136/neurintsurg-2019-015604,10.1136/neurintsurg-2019-015604,57.93545
337,,"Hamon, M, Pristipino, C, Mario, CD, et al. Consensus document on the radial approach in percutaneous cardiovascular interventions: position paper by the European association of percutaneous cardiovascular interventions and working groups on acute cardiac care** and thrombosis of the European society of cardiology [Internet]. EuroIntervention. [ citéd 2019 11 5]. Disponible sur: https://eurointervention.pcronline.com/article/consensus-document-on-the-radial-approach-in-percutaneous-cardiovascular-interventions-position-paper-by-the-european-association-of-percutaneous-cardiovascular-interventions-and-working-groups-on-acute-cardiac-care-and-thrombosis-of-the-european-society-of-cardiology",10.4244/eijv8i11a192,10.4244/eijv8i11a192,10.4244/eijv8i11a192,62.967903
338,10.1016/j.jcin.2011.08.011,"Uhlemann, M, Möbius-Winkler, S, Mende, M, et al. The leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications. JACC Cardiovasc Interv. 2012 1 1; 5(1): 36–43. PMID: 22230148",10.1016/j.jcin.2011.08.011,10.1016/j.jcin.2011.08.011,10.1016/j.jcin.2011.08.011,47.681038
339,10.1016/s0002-9149(98)00821-2,"Nagai, S, Abe, S, Sato, T, et al. Ultrasonic assessment of vascular complications in coronary angiography and angioplasty after transradial approach. Am J Cardiol. 1999 janv 15; 83(2): 180–186. PMID: 10073818",10.1016/s0002-9149(98)00821-2,10.1016/s0002-9149(98)00821-2,10.1016/s0002-9149(98)00821-2,39.406826
341,,"Mizuguchi, Y, Izumikawa, T, Hashimoto, S, et al. Efficacy and safety of the distal transradial approach in coronary angiography and percutaneous coronary intervention: a Japanese multicenter experience. Cardiovasc Interv Ther. 2019; 24.",10.1007/s12928-019-00590-0,10.1007/s12928-019-00590-0,10.1007/s12928-019-00590-0,52.1462
343,,"Okuyan, H, Hzal, F, Taçoy, G, et al. Angiographic evaluation of the radial artery diameter in patients who underwent coronary angiography or coronary intervention. J Invasive Cardiol. 2013 juill; 25(7): 353–357. PMID: 23813065",10.1016/j.jacc.2013.08.666,10.1016/j.jacc.2013.08.666,10.1016/j.jacc.2013.08.666,47.688763
344,,"Naito, T, Sawaoka, T, Sasaki, K, et al. Evaluation of the diameter of the distal radial artery at the anatomical snuff box using ultrasound in Japanese patients. Cardiovasc Interventions Ther [Internet] 2019 janv 7 [ citéd août 21]; Disponible sur; 34: 312–316.",10.1007/s12928-018-00567-5,10.1007/s12928-018-00567-5,10.1007/s12928-018-00567-5,49.98874
345,,"Davis, BJ, Roughley, SD. Fragment-based lead discovery. Annu Rep Med Chem 2017; 50: 371–439.",10.1016/bs.armc.2017.07.002,10.1016/bs.armc.2017.07.002,10.1016/bs.armc.2017.07.002,32.647385
346,10.1038/nchem.217,"Murray, CW, Rees, DC. The rise of fragment-based drug discovery. Nat Chem 2009; 1: 187–92. PMID: 21378847",10.1038/nchem.217,10.1038/nchem.217,10.1038/nchem.217,29.645788
347,10.1007/s10858-013-9740-z,"Harner, MJ, Frank, AO, Fesik, SW. Fragment-based drug discovery using NMR spectroscopy. J Biomol NMR 2013; 56: 65–75. PMID: 23686385",10.1007/s10858-013-9740-z,10.1007/s10858-013-9740-z,10.1007/s10858-013-9740-z,47.747543
348,,"Ma, R, Wang, P, Wu, J, Ruan, K. Process of fragment-based lead discovery –a perspective from NMR. Molecules 2016; 21: 854.",10.3390/molecules21070854,10.3390/molecules21070854,10.3390/molecules21070854,42.2424
349,10.1021/jm200558u,"Verdonk, ML, Giangreco, I, Hall, RJ, et al. Docking performance of fragments and druglike compounds. J Med Chem 2011; 54: 5422–31. PMID: 21692478",10.1021/jm200558u,10.1021/jm200558u,10.1021/jm200558u,41.25134
350,10.2174/156802612804547371,"Mortier, J, Rakers, C, Frederick, R, Wolber, G. Computational tools for in silico fragment-based drug design. Curr Top Med Chem 2012; 12: 1935–43. PMID: 23116473",10.2174/156802612804547371,10.2174/156802612804547371,10.2174/156802612804547371,43.372475
351,10.1111/j.1582-4934.2008.00665.x,"Zoete, V, Grosdidier, A, Michielin, O. Docking, virtual high throughput screening and in silico fragment-based drug design. J Cell Mol Med 2009; 13: 238–48. PMID: 19183238",10.1111/j.1582-4934.2008.00665.x,10.1111/j.1582-4934.2008.00665.x,10.1111/j.1582-4934.2008.00665.x,51.636803
352,10.1021/jm00067a013,"Caflisch, A, Miranker, A, Karplus, M. Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase. J Med Chem 1993; 36: 2142–67. PMID: 8340918",10.1021/jm00067a013,10.1021/jm00067a013,10.1021/jm00067a013,64.16289
353,10.1021/acs.jcim.7b00625,"Martinez-Rosell, G, Harvey, MJ, De Fabritiis, G. Molecular-simulation-driven fragment screening for the discovery of new CXCL12 inhibitors. J Chem Inf Model 2018; 58: 683–91. PMID: 29481075",10.1021/acs.jcim.7b00625,10.1021/acs.jcim.7b00625,10.1021/acs.jcim.7b00625,54.421337
354,10.1021/acs.jctc.9b00069,"Linker, SM, Magarkar, A, Köfinger, J, et al. Fragment binding pose predictions using unbiased simulations and Markov-state models. J Chem Theory Comput 2019; 15: 4974–81. PMID: 31402652",10.1021/acs.jctc.9b00069,10.1021/acs.jctc.9b00069,10.1021/acs.jctc.9b00069,57.709362
355,10.1021/ci400766b,"Sabbadin, D, Moro, S. Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale. J Chem Inf Model 2014; 54: 372–6. PMID: 24456045",10.1021/ci400766b,10.1021/ci400766b,10.1021/ci400766b,70.5432
356,10.1021/acs.jcim.5b00702,"Cuzzolin, A, Sturlese, M, Deganutti, G, et al. Deciphering the complexity of ligand-protein recognition pathways using supervised molecular dynamics (SuMD) simulations. J Chem Inf Model 2016; 56: 687–705. PMID: 27019343",10.1021/acs.jcim.5b00702,10.1021/acs.jcim.5b00702,10.1021/acs.jcim.5b00702,61.714493000000004
357,10.1016/j.str.2017.02.009,"Salmaso, V, Sturlese, M, Cuzzolin, A, Moro, S. Exploring protein-peptide recognition pathways using a supervised molecular dynamics approach. Structure 2017; 25: 655–62.e2. PMID: 28319010",10.1016/j.str.2017.02.009,10.1016/j.str.2017.02.009,10.1016/j.str.2017.02.009,58.549538
358,10.1038/nature03579,"Oltersdorf, T, Elmore, SW, Shoemaker, AR, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005; 435: 677–81. PMID: 15902208",10.3410/f.1026512.327607,10.1038/nature03579,10.1038/nature03579,31.603316999999997
359,10.1038/nrd.2016.253,"Ashkenazi, A, Fairbrother, WJ, Leverson, JD, Souers, AJ. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors. Nat Rev Drug Discov 2017; 16: 273–84. PMID: 28209992",10.1038/nrd.2016.253,10.1038/nrd.2016.253,10.1038/nrd.2016.253,59.63788
360,10.1016/j.compbiolchem.2018.08.007,"Maity, A, Majumdar, S, Ghosh Dastidar, S. Flexibility enables to discriminate between ligands: Lessons from structural ensembles of Bcl-xl and Mcl-1. Comput Biol Chem 2018; 77: 17–27. PMID: 30195235",10.1016/j.compbiolchem.2018.08.007,10.1016/j.compbiolchem.2018.08.007,10.1016/j.compbiolchem.2018.08.007,60.923492
361,10.1371/journal.pone.0064400,"Aguirre, C, ten Brink, T, Walker, O, et al. BcL-xL conformational changes upon fragment binding revealed by NMR. PLoS One 2013; 8: e64400. PMID: 23717610",10.1371/journal.pone.0064400,10.1371/journal.pone.0064400,10.1371/journal.pone.0064400,56.256443000000004
362,10.1016/b978-0-12-381274-2.00003-0,"Böttcher, J, Jestel, A, Kiefersauer, R, et al. Key factors for successful generation of protein-fragment structures: requirement on protein, crystals, and technology. Methods Enzymol 2011; 493: 61–89. PMID: 21371587",10.1016/b978-0-12-381274-2.00003-0,10.1016/b978-0-12-381274-2.00003-0,10.1016/b978-0-12-381274-2.00003-0,42.53208
363,10.1038/381335a0,"Muchmore, SW, Sattler, M, Liang, H, et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996; 381: 335–41. PMID: 8692274",10.1038/381335a0,10.1038/381335a0,10.1038/381335a0,39.03249
366,10.1002/jcc.20035,"Wang, J, Wolf, RM, Caldwell, JW, Kollman, PA, et al. Development and testing of a general amber force field. J Comput Chem 2004; 25: 1157–74. PMID: 15116359",10.1002/jcc.20035,10.1002/jcc.20035,10.1002/jcc.20035,39.795372
367,10.1093/nar/28.1.235,"Berman, HM, Westbrook, J, Feng, Z, et al. The protein data bank. Nucleic Acids Res 2000; 28: 235–42. PMID: 10592235",10.1093/nar/28.1.235,10.2210/rcsb_pdb/pdb-cit-anal-2017,10.1093/nar/28.1.235,21.765966
368,10.1110/ps.9.12.2528,"Petros, AM, Nettesheim, DG, Wang, Y, et al. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci 2000; 9: 2528–34. PMID: 11206074",10.1017/s096183680000331x,10.1110/ps.9.12.2528,10.1017/s096183680000331x,43.186172
369,,"Labute, P. Protonate 3D: assignment of macromolecular protonation state and geometry. Chem Comput Gr. 2007: 1–17.",10.1186/1752-153x-2-s1-s13,10.1186/1752-153x-2-s1-s13,10.1002/prot.22234,18.578506
371,10.1016/j.jmgm.2005.12.005,"Wang, J, Wang, W, Kollman, PA, Case, DA. Automatic atom type and bond type perception in molecular mechanical calculations. J Mol Graph Model 2006; 25: 247–60. PMID: 16458552",10.1016/j.jmgm.2005.12.005,10.1016/j.jmgm.2005.12.005,10.1016/j.jmgm.2005.12.005,41.71528
372,,"Jakalian, A, Bush, BL, Jack, DB, Bayly, CI. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method. J Comput Chem 2000; 21: 132–46.",10.1002/(sici)1096-987x(20000130)21:2<132::aid-jcc5>3.0.co;2-p,10.1002/(sici)1096-987x(20000130)21:2<132::aid-jcc5>3.0.co;2-p,10.1002/(sici)1096-987x(20000130)21:2<132::aid-jcc5>3.0.co;2-p,50.560608
373,10.1002/jcc.10128,"Jakalian, A, Jack, DB, Bayly, CI. Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation. J Comput Chem 2002; 23: 1623–41. PMID: 12395429",10.1002/jcc.10128,10.1002/jcc.10128,10.1002/jcc.10128,60.528659999999995
374,,"Berendsen, HJC, Postma, JPM, van Gunsteren, WF, et al. Molecular dynamics with coupling to an external bath. J Chem Phys 1984; 81: 3684–90.",10.1063/1.448118,10.1063/1.448118,10.1063/1.448118,38.894657
375,10.1093/bioinformatics/btr168,"Bakan, A, Meireles, LM, Bahar, I. ProDy: protein dynamics inferred from theory and experiments. Bioinformatics 2011; 27: 1575–7. PMID: 21471012",10.1093/bioinformatics/btr168,10.1093/bioinformatics/btr168,10.1093/bioinformatics/btr168,51.96072
378,,"Humphrey, W, Dalke, A, Schulten, K. VMD: visual molecular dynamics. J Mol Graph 1996; 14: 3333–8.",10.1016/0263-7855(96)00018-5,10.1016/0263-7855(96)00018-5,10.1016/0263-7855(96)00018-5,32.088814
380,10.1007/s10858-005-4425-x,"Schanda, P, Kupce, E, Brutscher, B. SOFAST-HMQC experiments for recording two-dimensional heteronuclear correlation spectra of proteins within a few seconds. J Biomol NMR 2005; 33: 199–211. PMID: 16341750",10.1007/s10858-005-4425-x,10.1007/s10858-005-4425-x,10.1007/s10858-005-4425-x,65.2182
381,10.1021/acs.jproteome.6b00121,"Stark, JL, Eghbalnia, HR, Lee, W, et al. NMRmix: a tool for the optimization of compound mixtures in 1D (1)H NMR ligand affinity screens. J Proteome Res 2016; 15: 1360–8. PMID: 26965640",10.1021/acs.jproteome.6b00121,10.1021/acs.jproteome.6b00121.s001,10.1021/acs.jproteome.6b00121,56.680916
382,10.1093/nar/gkm957,"Ulrich, EL, Akutsu, H, Doreleijers, JF, et al. BioMagResBank. Nucleic Acids Res 2008; 36: D402–8. PMID: 17984079",10.1093/nar/gkm957,10.1093/nar/gkm957,10.1093/nar/gkm957,28.274890000000003
383,10.1016/j.pnmrs.2013.02.001,"Williamson, MP. Using chemical shift perturbation to characterise ligand binding. Prog Nucl Magn Reson Spectrosc 2013; 73: 1–16. PMID: 23962882",10.1016/j.pnmrs.2014.05.001,10.1016/j.pnmrs.2014.05.001,10.1016/j.pnmrs.2014.05.001,42.448135
384,,"Mayer, M, Meyer, B. Characterization of ligand binding by saturation transfer difference NMR spectroscopy. Angew Chem Int Ed 1999; 38: 1784–8.",10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-q,10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-q,10.1002/(sici)1521-3773(19990614)38:12<1784::aid-anie1784>3.0.co;2-q,43.137806
385,10.1023/a:1013302231549,"Dalvit, C, Fogliatto, G, Stewart, A, et al. WaterLOGSY as a method for primary NMR screening: practical aspects and range of applicability. J Biomol NMR 2001; 21: 349–59. PMID: 11824754",10.1023/a:1013302231549,EXCEPTION: 'title',10.1023/a:1013302231549,25.659983
386,,"Hwang, TL, Shaka, AJ. Water suppression that works. excitation sculpting using arbitrary wave-forms and pulsed-field gradients. J Magn Reson Ser A 1995; 112: 275–9.",10.1006/jmra.1995.1047,10.1006/jmra.1995.1047,10.1006/jmra.1995.1047,52.68626
387,10.1093/bioinformatics/btu830,"Lee, W, Tonelli, M, Markley, JL. NMRFAM-SPARKY: enhanced software for biomolecular NMR spectroscopy. Bioinformatics 2015; 31: 1325–7. PMID: 25505092",10.1093/bioinformatics/btu830,10.1093/bioinformatics/btu830,10.1093/bioinformatics/btu830,53.678387
388,,"Bienstock, RJ. Overview: fragment-based drug design In, Bienstock, RJ, ed. Library design, search methods, and applications of fragment-based drug design. Vol. 1076 ACS Symposium Series. Washington (DC): American Chemical Society; 2011: 1–26.",10.1021/bk-2011-1076.ch001,10.1021/bk-2011-1076.ch001,10.1021/bk-2011-1076.ch001,52.366917
389,10.1021/jm100009z,"Barelier, S, Pons, J, Marcillat, O, et al. Fragment-based deconstruction of Bcl-xL inhibitors. J Med Chem 2010; 53: 2577–88. PMID: 20192224",10.1021/jm100009z,10.1021/jm100009z,10.1021/jm100009z,43.566208
391,10.1021/acs.jmedchem.8b01855,"Giordanetto, F, Jin, C, Willmore, L, et al. Fragment hits: what do they look like and how do they bind? J Med Chem 2019; 62: 3381–94. PMID: 30875465",10.1021/acs.jmedchem.8b01855,10.1021/acs.jmedchem.8b01855,10.1021/acs.jmedchem.8b01855,58.89059
392,10.1021/ci200608b,"Ferenczy, GG, Keserű, GM. Thermodynamics of fragment binding. J Chem Inf Model 2012; 52: 1039–45. PMID: 22458364",10.1021/ci200608b,10.1021/ci200608b,10.1021/ci200608b,38.781662
393,10.1023/a:1008354229396,"Dalvit, C, Pevarello, P, Tatò, M, et al. Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water. J Biomol NMR 2000; 18: 65–8. PMID: 11061229",10.1023/a:1008354229396,EXCEPTION: 'title',10.1023/a:1008354229396,26.7561
394,10.1016/j.pnmrs.2016.09.001,"Gossert, AD, Jahnke, W. NMR in drug discovery: a practical guide to identification and validation of ligands interacting with biological macromolecules. Prog Nucl Magn Reson Spectrosc 2016; 97: 82–125. PMID: 27888841",10.1016/j.pnmrs.2016.09.001,10.1016/j.pnmrs.2016.09.001,10.1016/j.pnmrs.2016.09.001,50.153605999999996
395,10.1021/jm0507532,"Petros, AM, Dinges, J, Augeri, DJ, et al. Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis. J Med Chem 2006; 49: 656–63. PMID: 16420051",10.1021/jm0507532.s001,10.1021/jm0507532.s001,10.1021/jm0507532,42.0803
396,10.1074/jbc.m306021200,"Manion, MK, O'Neill, JW, Giedt, CD, et al. Bcl-XL mutations suppress cellular sensitivity to antimycin A. J Biol Chem 2004; 279: 2159–65. PMID: 14534311",10.1074/jbc.m306021200,10.1074/jbc.m306021200,10.1074/jbc.m306021200,38.623135
397,10.1016/j.chembiol.2018.10.001,"Erlanson, DA, Davis, BJ, Jahnke, W. Fragment-based drug discovery: advancing fragments in the absence of crystal structures. Cell Chem Biol 2019; 26: 9–15. PMID: 30482678",10.1016/j.chembiol.2018.10.001,10.1016/j.chembiol.2018.10.001,10.1016/j.chembiol.2018.10.001,45.692753
398,10.1177/1087057112465979,"Wielens, J, Headey, SJ, Rhodes, DI, et al. Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification? J Biomol Screen 2013; 18: 147–59. PMID: 23139382",10.1177/1087057112465979,10.1177/1087057112465979,10.1177/1087057112465979,39.80747
399,10.1152/physrev.00038.2009,"Chudakov, DM, Matz, MV, Lukyanov, S, Lukyanov, KA. Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev 2010; 90: 1103–63. PMID: 20664080",10.1152/physrev.00038.2009,10.1152/physrev.00038.2009,10.1152/physrev.00038.2009,50.5808
400,10.1038/srep17740,"Liss, V, Barlag, B, Nietschke, M, Hensel, M. Self-labelling enzymes as universal tags for fluorescence microscopy, super-resolution microscopy and electron microscopy. Sci Rep 2015; 5: 17740–52. PMID: 26643905",10.1038/srep17740,10.1038/srep17740,10.1038/srep17740,69.48465
401,,"Hatlem, D, Trunk, T, Linke, D, Leo, JC. Catching a SPY: using the SpyCatcher-SpyTag and related systems for labeling and localizing bacterial proteins. Int J Mol Sci 2019; 20: 2129–39.",10.3390/ijms20092129,10.3390/ijms20092129,10.3390/ijms20092129,66.77813
402,10.1021/cb800025k,"Los, GV, Encell, LP, McDougall, MG, et al. HaloTag: a novel protein labeling technology for cell imaging and protein analysis. ACS Chem Biol 2008; 3: 373–82. PMID: 18533659",10.1021/cb800025k,10.1021/cb800025k,10.1021/cb800025k,32.97358
403,10.1021/acs.bioconjchem.5b00191,"England, CG, Luo, H, Cai, W. HaloTag technology: a versatile platform for biomedical applications. Bioconjug Chem 2015; 26: 975–86. PMID: 25974629",10.1021/acs.bioconjchem.5b00191,10.1021/acs.bioconjchem.5b00191,10.1021/acs.bioconjchem.5b00191,39.52541
404,10.1016/s1383-5742(00)00017-x,"Pegg, AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000; 462: 83–100. PMID: 10767620",10.1016/s1383-5742(00)00017-x,10.1016/s1383-5742(00)00017-x,10.1016/s1383-5742(00)00017-x,35.774254
405,10.1093/emboj/19.7.1719,"Daniels, DS, Mol, CD, Arvai, AS, et al. Active and alkylated human AGT structures: a novel zinc site, inhibitor and extrahelical base binding. Embo J 2000; 19: 1719–30. PMID: 10747039",10.1093/emboj/19.7.1719,10.1093/emboj/19.7.1719,10.1093/emboj/19.7.1719,52.718219999999995
406,10.1038/nsmb791,"Daniels, DS, Woo, TT, Luu, KX, et al. DNA binding and nucleotide flipping by the human DNA repair protein AGT. Nat Struct Mol Biol 2004; 11: 714–20. PMID: 15221026",10.1038/nsmb791,10.1038/nsmb791,10.1038/nsmb791,48.838947
407,10.1038/nbt765,"Keppler, A, Gendreizig, S, Gronemeyer, T, et al. A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat Biotechnol 2003; 21: 86–9. PMID: 12469133",10.1038/nbt765,10.1038/nbt765,10.1038/nbt765,52.03138
408,,"Keppler, A, Pick, H, Arrivoli, C, et al. Labeling of fusion proteins with synthetic fluorophores in live cells. Proc Natl Acad Sci USA 2004; 10: 9955–9.",10.1073/pnas.0401923101,10.1073/pnas.0401923101,10.1073/pnas.0401923101,45.57719
409,10.1016/s1074-5521(03)00068-1,"Juillerat, A, Gronemeyer, T, Keppler, A, et al. Directed evolution of O6-alkylguanine-DNA alkyltransferase for efficient labeling of fusion proteins with small molecules in vivo. Chem Biol 2003; 10: 313–7. PMID: 12725859",10.1016/s1074-5521(03)00068-1,10.1016/s1074-5521(03)00068-1,10.1016/s1074-5521(03)00068-1,53.935340000000004
410,10.1093/protein/gzl014,"Gronemeyer, T, Chidley, C, Juillerat, A, et al. Directed evolution of O6-alkylguanine-DNA alkyltransferase for applications in protein labeling. Protein Eng Des Sel 2006; 19: 309–16. PMID: 16638797",10.1093/protein/gzl014,10.1093/protein/gzl014,10.1093/protein/gzl014,58.676494999999996
411,10.1021/bi2016537,"Mollwitz, B, Brunk, E, Schmitt, S, et al. Directed evolution of the suicide protein O6-alkylguanine-DNA alkyltransferase for Increased reactivity results in an alkylated protein with exceptional stability. Biochemistry 2012; 51: 986–94. PMID: 22280500",10.1021/bi2016537,10.1021/bi2016537,10.1021/bi2016537,65.596634
412,10.1016/j.chembiol.2008.01.007,"Gautier, A, Juillerat, A, Heinis, C, et al. An engineered protein tag for multiprotein labeling in living cells. Chem Biol 2008; 15: 128–36. PMID: 18291317",10.1016/j.chembiol.2008.01.007,10.1016/j.chembiol.2008.01.007,10.1016/j.chembiol.2008.01.007,42.334827000000004
413,10.1038/s41592-018-0017-z,"Vogel, P, Moschref Merkle, MM, Li, Q, et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat Methods 2018; 15: 535–8. PMID: 29967493",10.1038/s41592-018-0017-z,10.1038/s41592-018-0017-z,10.1038/s41592-018-0017-z,53.80734
414,10.1021/ja100117u,"Srikun, D, Albers, AE, Nam, CI, et al. Organelle-targetable fluorescent probes for imaging hydrogen peroxide in living cells via SNAP-Tag protein labeling. J Am Chem Soc 2010; 132: 4455–65. PMID: 20201528",10.1021/ja100117u,10.1021/ja100117u,10.1021/ja100117u,64.66211
415,10.1021/ac501041w,"Abo, M, Minakami, R, Miyano, K, et al. Visualization of phagosomal hydrogen peroxide production by a novel fluorescent probe that is localized via SNAP-tag labeling. Anal Chem 2014; 86: 5983–90. PMID: 24862209",10.1021/ac501041w,10.1021/ac501041w,10.1021/ac501041w,63.623619999999995
416,10.1038/nchembio.1554,"Griss, R, Schena, A, Reymond, L, et al. Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring. Nat Chem Biol 2014; 10: 598–603. PMID: 24907901",10.1038/nchembio.1554,10.1038/nchembio.1554,10.1038/nchembio.1554,47.26866
417,10.1021/ja806634e,"Tomat, E, Nolan, EM, Jaworski, J, Lippard, SJ. Organelle-specific zinc detection using zinpyr-labeled fusion proteins in live cells. J Am Chem Soc 2008; 130: 15776–7. PMID: 18973293",10.1021/ja806634e,10.1021/ja806634e,10.1021/ja806634e,65.93341
418,10.1021/ac100741t,"Kamiya, M, Johnsson, K. Localizable and highly sensitive calcium indicator based on a BODIPY fluorophore. Anal Chem 2010; 82: 6472–9. PMID: 20590099",10.1021/ac100741t,10.1021/ac100741t,10.1021/ac100741t,55.481102
419,10.1002/anie.201005931,"Saccà, B, Meyer, R, Erkelenz, M, et al. Orthogonal protein decoration of DNA origami. Angew Chem Int Ed Engl 2010; 49: 9378–83. PMID: 21031395",10.1002/anie.201005931,10.1002/anie.201005931,10.1002/anie.201005931,43.43385
420,10.1074/jbc.m111.308320,"Perugino, G, Vettone, A, Illiano, G, et al. Activity and regulation of archaeal DNA alkyltransferase: conserved protein involved in repair of DNA alkylation damage. J Biol Chem 2012; 287: 4222–31. PMID: 22167184",10.1074/jbc.a111.308320,10.1074/jbc.m111.308320,10.1074/jbc.a111.308320,54.980309999999996
421,10.1093/nar/gkv774,"Perugino, G, Miggiano, R, Serpe, M, et al. Structure-function relationships governing activity and stability of a DNA alkylation damage repair thermostable protein. Nucleic Acids Res 2015; 43: 8801–16. PMID: 26227971",10.1093/nar/gkv774,10.1093/nar/gkv774,10.1093/nar/gkv774,53.696583
422,10.1007/s00792-015-0791-9,"Vettone, A, Serpe, M, Hidalgo, A, et al. A novel thermostable protein-tag: optimization of the Sulfolobus solfataricus DNA-alkyl-transferase by protein engineering. Extremophiles 2016; 20: 1–13. PMID: 26499124",10.1007/s00792-015-0791-9,10.1007/s00792-015-0803-9,10.1007/s00792-015-0791-9,57.227116
423,10.1371/journal.pone.0185791,"Visone, V, Han, W, Perugino, G, et al. In vivo and in vitro protein imaging in thermophilic archaea by exploiting a novel protein tag. PloS One 2017; 12: e0185791. PMID: 28973046",10.1371/journal.pone.0185791,10.1371/journal.pone.0185791,10.1371/journal.pone.0185791,56.154655000000005
424,10.1155/2019/9848253,"Lo Gullo, G, Mattossovich, R, Perugino, G, et al. Optimization of an in vitro transcription/translation system based on Sulfolobus solfataricus cell lysate. Archaea 2019; 2019: 9848253. PMID: 30886540",10.1155/2019/9848253,10.1155/2019/9848253,10.1155/2019/9848253,64.11446
425,10.1080/14756366.2018.1559161,"Merlo, R, Del Prete, S, Valenti, A, et al. An AGT-based protein-tag system for the labelling and surface immobilization of enzymes on E. coli outer membrane. J Enzyme Inhib Med Chem 2019; 34: 490–9. PMID: 30724623",10.1080/14756366.2018.1559161,10.1080/14756366.2018.1559161,10.1080/14756366.2018.1559161,50.166576
426,10.1080/14756366.2019.1605991,"Del Prete, S, Merlo, R, Valenti, A, et al. Thermostability enhancement of the α-carbonic anhydrase from Sulfurihydrogenibium yellowstonense by using the anchoring-and-self-labelling-protein-tag system (ASL tag). J Enzyme Inhib Med Chem 2019; 34: 946–54. PMID: 31039618",10.1080/14756366.2019.1605991,10.1080/14756366.2019.1605991,10.1080/14756366.2019.1605991,61.763542
427,10.1021/jm00101a028,"Moschel, RC, McDougall, MG, Dolan, ME, et al. Structural features of substituted purine derivatives compatible with depletion of human O6-alkylguanine-DNA alkyltransferase. J Med Chem 1992; 35: 4486–91. PMID: 1447749",10.1021/jm00101a028,10.1021/jm00101a028,10.1021/jm00101a028,61.147118000000006
428,10.1021/jm00029a005,"Chae, MY, McDougall, MG, Dolan, ME, et al. Substituted O6-benzylguanine derivatives and their inactivation of human O6-alkylguanine-DNA alkyltransferase. J Med Chem 1994; 37: 342–7. PMID: 8308861",10.1021/jm00029a005,10.1021/jm00029a005,10.1021/jm00029a005,59.705256999999996
429,10.1021/tx9700580,"Terashima, I, Kawate, H, Sakumi, K, et al. Substrate specificity of human O6-methylguanine-DNA methyltransferase for O6-benzylguanine derivatives in oligodeoxynucleotides. Chem Res Toxicol 1997; 10: 1234–9. PMID: 9403175",10.1021/tx9700580,10.1021/tx9700580,10.1021/tx9700580,56.95414
430,10.1021/jm9708644,"McElhinney, RS, Donnelly, DJ, McCormick, JE, et al. Inactivation of O6-alkylguanine-DNA alkyltransferase. 1. Novel O6-(hetarylmethyl)guanines having basic rings in the side chain. J Med Chem 1998; 41: 5265–71. PMID: 9857094",10.1021/jm9708644,10.1021/jm9708644,10.1021/jm9708644,41.380844
431,,"Sun, G, Fan, T, Zhang, N, et al. Identification of the structural features of guanine derivatives as MGMT inhibitors using 3D-QSAR modeling combined with molecular docking. Molecules 2016; 21: 823–44.",10.3390/molecules21070823,10.3390/molecules21070823,10.3390/molecules21070823,52.750057
432,10.1021/ol201430x,"Zhang, CJ, Li, L, Chen, GYJ, et al. One-and two-photon live cell imaging using a mutant SNAP-Tag protein and its FRET substrate pairs. Org Lett 2011; 13: 4160–3. PMID: 21786765",10.1021/ol201430x,10.1021/ol201430x,10.1021/ol201430x,50.757652
433,10.1016/j.ejmech.2016.10.067,"Huang, M, Deng, Z, Tian, J, Liu, T. Synthesis and biological evaluation of salinomycin triazole analogues as anticancer agents. Eur J Med Chem 2017; 127: 900–8. PMID: 27876192",10.1016/j.ejmech.2016.10.067,10.1016/j.ejmech.2016.10.067,10.1016/j.ejmech.2016.10.067,43.16377
434,,"Leng, S, Qiao, Q, Miao, L, et al. A wash-free SNAP-tag fluorogenic probe based on the additive effects of quencher release and environmental sensitivity. Chem Commun 2017; 53: 6448–51.",10.1039/c7cc01483j,10.1039/c7cc01483j,10.1039/c7cc01483j,59.039680000000004
435,10.1021/ja034145s,"Kindermann, M, George, N, Johnsson, N, Johnsson, K. Covalent and selective immobilization of fusion proteins. J Am Chem Soc 2003; 125: 7810–1. PMID: 12822993",10.1021/ja034145s,10.1021/ja034145s,10.1021/ja034145s,53.297688
436,10.1007/s00792-019-01134-3,"Mattossovich, R, Merlo, R, Fontana, A, et al. A journey down to hell: new thermostable protein-tags for biotechnology at high temperatures. Extremophiles 2020; 24: 81–91. PMID: 31555904",10.1007/s00792-019-01134-3,10.1007/s00792-019-01134-3,10.1007/s00792-019-01134-3,52.537780000000005
437,10.1016/j.bbrc.2018.04.139,"Rossi, F, Morrone, C, Massarotti, A, et al. Crystal structure of a thermophilic O6-alkylguanine-DNA alkyltransferase-derived self-labeling protein-tag in covalent complex with a fluorescent probe. Biochem Biophys Res Commun 2018; 500: 698–703. PMID: 29684348",10.1016/j.bbrc.2018.04.139,10.2210/pdb6ga0/pdb,10.1016/j.bbrc.2018.04.139,62.87514
438,10.1002/jcc.20292,"Banks, JL, Beard, HS, Cao, Y, et al. Integrated Modeling Program, Applied Chemical Theory (IMPACT). J Comput Chem 2005; 26: 1752–80. PMID: 16211539",10.1002/jcc.20292,10.1002/jcc.20292,10.1002/jcc.20292,25.553086999999998
439,,"Toukmaji, AY, Board, JA, Jr,. Ewald summation techniques in perspective: a survey. Comput Phys Commun 1996; 95: 73–92.",10.1016/0010-4655(96)00016-1,10.1016/0010-4655(96)00016-1,10.1016/0010-4655(96)00016-1,35.744164000000005
440,10.1063/1.2018637,"Zielkiewicz, J. Structural properties of water: comparison of the SPC, SPCE, TIP4P, and TIP5P models of water. J Chem Phys 2005; 123: 104501. PMID: 16178604",10.1063/1.2178809,10.1063/1.2018637,10.1063/1.2018637,58.725376000000004
441,,"Martyna, GJ, Klein, ML, Tuckerman, M. Reversible multiple time scale molecular dynamics. J Chem Phys 1992; 97: 2635–43.",10.1063/1.463137,10.1063/1.463137,10.1063/1.463137,31.701569
442,,"Evans, DJ, Holian, BL. The Nose–Hoover thermostat. J Chem Phys 1985; 3: 4069.",10.1063/1.449071,10.1063/1.449071,10.1063/1.449071,31.715624
443,10.1042/bj20150833,"Miggiano, R, Perugino, G, Ciaramella, M, et al. Crystal structure of Mycobacterium tuberculosis O6-methylguanine-DNA methyltransferase protein clusters assembled on to damaged DNA. Biochem J 2016; 473: 123–33. PMID: 26512127",10.1042/bj20150833,10.1042/bj20150833,10.1042/bj20150833,56.391514
444,10.1016/j.bbagen.2016.10.020,"Morrone, C, Miggiano, R, Serpe, M, et al. Interdomain interactions rearrangements control the reaction steps of a thermostable DNA alkyltransferase. Biochim Biophys Acta Gen Subj 2017; 1861: 86–96. PMID: 27777086",10.1016/j.bbagen.2016.10.020,10.1016/j.bbagen.2016.10.020,10.1016/j.bbagen.2016.10.020,46.154305
445,10.1158/1078-0432.ccr-05-2198,"Ranson, M, Middleton, MR, Bridgewater, J, et al. Lomeguatrib, a potent inhibitor of O6-alkylguanine-DNA-alkyltransferase: phase I safety, pharmacodynamic, and pharmacokinetic trial and evaluation in combination with temozolomide in patients with advanced solid tumors. Clin Cancer Res 2006; 12: 1577–84. PMID: 16533784",10.1158/1078-0432.ccr-05-2198,10.1158/1078-0432.ccr-05-2198,10.1158/1078-0432.ccr-05-2198,70.42175
446,10.1002/smll.201102284,"Colombo, M, Mazzucchelli, S, Montenegro, JM, et al. Protein oriented ligation on nanoparticles exploiting O6-alkylguanine-DNA transferase (SNAP) genetically encoded fusion. Small 2012; 8: 1492–7. PMID: 22431243",10.1002/smll.201102284,10.1002/smll.201102284,10.1002/smll.201102284,59.37611999999999
447,,"Song, X, Wang, C, Han, Z, et al. Terminal alkyne substituted O6-benzylguanine for versatile and effective syntheses of fluorescent labels to genetically encoded SNAP-tags. RSC Adv 2015; 5: 23646–9.",10.1039/c4ra17072e,10.1039/c4ra17072e,10.1039/c4ra17072e,68.86601999999999
448,10.1002/prot.24548,"Ferraris, DM, Spallek, R, Oehlmann, W, et al. Structure of Thermococcus litoralis Δ 1‐pyrroline‐2‐carboxylate reductase in complex with NADH and L‐proline. Proteins 2014; 82: 2268–74. PMID: 24615888",10.2210/pdb6t3e/pdb,10.2210/pdb6t3e/pdb,10.2210/pdb6t3e/pdb,47.237583
449,10.1016/j.ab.2004.05.058,"Huber, W, Perspicace, S, Kohler, J, et al. SPR-based interaction studies with small molecular weight ligands using hAGT fusion proteins. Anal Biochem 2004; 333: 280–8. PMID: 15450803",10.1016/j.ab.2004.05.058,10.1016/j.ab.2004.05.058,10.1016/j.ab.2004.05.058,53.01922
450,10.1021/acs.bioconjchem.6b00315,"Niesen, J, Sack, M, Seidel, M, et al. SNAP-Tag technology: a useful tool to determine affinity constants and other functional parameters of novel antibody fragments. Bioconjug Chem 2016; 27: 1931–41. PMID: 27391930",10.1021/acs.bioconjchem.6b00315,10.1021/acs.bioconjchem.6b00315,10.1021/acs.bioconjchem.6b00315,54.19218000000001
451,10.1016/j.bpj.2010.08.012,"Testa, I, Wurm, CA, Medda, R, et al. Multicolor fluorescence nanoscopy in fixed and living cells by exciting conventional fluorophores with a single wavelength. Biophys J 2010; 99: 2686–94. PMID: 20959110",10.1016/j.bpj.2010.08.012,10.1016/j.bpj.2010.08.012,10.1016/j.bpj.2010.08.012,49.358222999999995
452,,"Miggiano, R, Valenti, A, Rossi, F, et al. Every OGT is illuminated … by fluorescent and synchrotron lights. Int J Mol Sci 2017; 18: 2613–31.",10.3390/ijms18122613,10.3390/ijms18122613,10.3390/ijms18122613,49.703247
453,10.1038/ncomms15352,"Zweerink, S, Kallnik, V, Ninck, S, et al. Activity-based protein profiling as a robust method for enzyme identification and screening in extremophilic Archaea. Nat Commun 2017; 8: 15352. PMID: 28480883",10.1038/ncomms15352,10.1038/ncomms15352,10.1038/ncomms15352,47.34195
